subject: UMLS:C2987377

object_name: Stage IV Primary Peritoneal Cancer AJCC v7


subject: UMLS:C2987377

subject_name: pUMVC3-hIGFBP-2 Multi-epitope Plasmid DNA Vaccine

object_name: Stage III Fallopian Tube Cancer AJCC v6

tested_intervention: unsure


subject: UMLS:C2987377

object_name: Stage III Fallopian Tube Cancer AJCC v7


subject: UMLS:C2987377

object_name: Stage III Fallopian Tube Cancer AJCC v8


subject: UMLS:C2987377

object_name: Stage IIIA Ovarian Cancer AJCC v6 and v7


subject: UMLS:C2987377

object_name: Stage IIIA Ovarian Cancer AJCC v8


subject: UMLS:C2987377

object_name: Stage IIIC Ovarian Cancer AJCC v8


subject: UMLS:C2987377

object_name: Stage IIIC Ovarian Cancer


subject: UMLS:C2987377

object_name: Stage IIIB Ovarian Cancer AJCC v6 and v7


subject: UMLS:C2987377

object_name: Stage IIIB Ovarian Cancer AJCC v8


subject: UMLS:C2987377

object_name: Stage IIIA Fallopian Tube Cancer AJCC v7


subject: UMLS:C2987377

object_name: Stage IIIA Fallopian Tube Cancer AJCC v8


subject: UMLS:C2987377

object_name: Stage IIIC Fallopian Tube Cancer AJCC v8


subject: UMLS:C2987377

object_name: Stage IIIC Fallopian Tube Cancer AJCC v7


subject: UMLS:C2987377

object_name: Stage IIIB Fallopian Tube Cancer AJCC v7


subject: UMLS:C2987377

object_name: Stage IIIB Fallopian Tube Cancer AJCC v8


subject: UMLS:C2987377

object_name: Stage IV Fallopian Tube Cancer AJCC v6 and v7


subject: UMLS:C2987377

object_name: Stage IV Fallopian Tube Cancer AJCC v8


subject: UMLS:C4725693

subject_name: FGFR1/2/3 Inhibitor HMPL-453

object_name: intrahepatic cholangiocarcinoma


subject: CHEMBL.COMPOUND:CHEMBL4650297


subject: CHEBI:8768

subject_name: Rabeprazole


subject: CHEBI:95165

object_name: lymphoma, non-Hodgkin, familial


subject: CHEBI:95165

object_name: Lymphoma, Large-Cell, Follicular


subject: CHEBI:50131

subject_name: Decitabine


subject: CHEBI:50131


subject: UMLS:C1100687

subject_name: Xigris

object_name: adult acute respiratory distress syndrome

tested_intervention: yes


subject: UMLS:C1832020

subject_name: mycobacterial cell wall-DNA complex

object_name: bladder tumor


subject: UMLS:C2826229

object_name: salivary gland carcinoma


subject: UMLS:C2826229

object_name: salivary gland cancer


subject: UMLS:C2826229

object_name: ERBB2 Gene Mutation


subject: UMLS:C3643461

subject_name: ADO-TRASTUZUMAB


subject: UMLS:C3643461


subject: UMLS:C3643461


subject: PUBCHEM.COMPOUND:72832535

subject_name: Maytansinoid DM4


subject: PUBCHEM.COMPOUND:72832535


subject: PUBCHEM.COMPOUND:72832535


subject: UMLS:C4505403

subject_name: Maytansinoid DM1


subject: UMLS:C4505403


subject: UMLS:C4505403


subject: UMLS:C0308312

subject_name: amino acid solution

object_name: paraganglioma


subject: UMLS:C0308312

object_name: adrenal gland pheochromocytoma


subject: UMLS:C0308312

object_name: pheochromocytoma


subject: UMLS:C0308312

object_name: neuroendocrine neoplasm


subject: UMLS:C1619357

subject_name: Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries


subject: UMLS:C1619357


subject: UMLS:C1619357


subject: UNII:9G6U5L461Q

subject_name: Icotinib

object_name: non-small cell squamous lung carcinoma


subject: UNII:1P05PW62F3

subject_name: CONBERCEPT

object_name: uveitis


subject: UNII:1P05PW62F3

object_name: Uveitis, CTCAE


subject: UNII:1P05PW62F3

object_name: choroidal neovascularization


subject: UNII:1P05PW62F3

object_name: choroidal neovascularization (physical finding)


subject: UMLS:C2352201

subject_name: Conbercept


subject: UMLS:C2352201


subject: UMLS:C2352201


subject: UMLS:C2352201


subject: UMLS:C4727072

subject_name: EGFR Mutant-specific Inhibitor ZN-e4

object_name: non-small cell lung carcinoma


subject: CHEBI:5558

subject_name: Guanfacine

object_name: chronic pain (diagnosis)


subject: CHEBI:5558

object_name: Chronic pain


subject: CHEBI:3756

subject_name: Clonazepam

object_name: Cannabis use disorder


subject: PUBCHEM.COMPOUND:656509

subject_name: Lincomycin

object_name: Status epilepticus


subject: PUBCHEM.COMPOUND:656509

object_name: epilepsy


subject: CHEBI:8107

subject_name: Phenytoin

object_name: cocaine abuse


subject: UMLS:C5203352

subject_name: Carboplatin Liquid Injection

object_name: endometrium neoplasm


subject: UMLS:C0499106

subject_name: Injection, carboplatin, 50 mg


subject: RXCUI:1945215

subject_name: meropenem / vaborbactam Injectable Product

object_name: bacterial infectious disease


subject: CHEBI:36467

subject_name: Ciguatoxins

object_name: leukemia


subject: CHEBI:36467

object_name: childhood leukemia


subject: CHEBI:204928

subject_name: Cefotaxime


subject: CHEBI:204928


subject: UMLS:C5574748

subject_name: C-Terminal Telopeptide Type 1 Collagen, human


subject: UMLS:C5574748


subject: UMLS:C0010377

subject_name: Crotoxin


subject: UMLS:C0010377


subject: UniProtKB:P41416

subject_name: CXOL_NPVAC Conotoxin-like peptide (sprot)


subject: UniProtKB:P41416


subject: CHEBI:91398

subject_name: Tivantinib


subject: UNII:R8DG7T2D3A

subject_name: FERUMOXYTOL

object_name: Childhood Soft Tissue Sarcoma


subject: UNII:R8DG7T2D3A

object_name: Adult Soft Tissue Sarcoma


subject: UNII:R8DG7T2D3A

object_name: sarcoma


subject: UNII:R8DG7T2D3A

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: UNII:R8DG7T2D3A

object_name: soft tissue sarcoma


subject: UNII:CLH5FT6412

subject_name: Ferumoxytol


subject: UNII:CLH5FT6412


subject: UNII:CLH5FT6412


subject: UNII:CLH5FT6412


subject: UNII:CLH5FT6412


subject: CHEBI:46726

subject_name: magnetite


subject: CHEBI:46726


subject: CHEBI:46726


subject: CHEBI:46726


subject: CHEBI:46726


subject: CHEMBL.COMPOUND:CHEMBL2109330

object_name: dengue disease


subject: UMLS:C5417932

subject_name: IC 14


subject: GTOPDB:9109

object_name: Neoplasm Metastasis


subject: GTOPDB:9109

object_name: neoplasm


subject: UMLS:C3273043


subject: UMLS:C0873137

subject_name: Korean ginseng preparation

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UMLS:C0873137

object_name: obesity


subject: UMLS:C0873137

object_name: Obesity, CTCAE


subject: DRUGBANK:DB01404

subject_name: Ginseng


subject: DRUGBANK:DB01404


subject: DRUGBANK:DB01404


subject: CHEBI:23965

subject_name: estradiol

object_name: fear; examination, phobic


subject: UNII:5S371K6132

subject_name: Rivoceranib

object_name: hepatobiliary neoplasm


subject: GTOPDB:9758

subject_name: camrelizumab


subject: GTOPDB:9758

object_name: cholangiocarcinoma


subject: UNII:73096E137E


subject: UNII:73096E137E


subject: UMLS:C4085979


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: dyskinesia of esophagus


subject: UMLS:C2606533

subject_name: Hemospan

object_name: Hypoxemia


subject: UMLS:C2606533

object_name: Hypoxia, CTCAE


subject: CHEBI:63618

subject_name: Pravastatin

object_name: lung cancer


subject: CHEBI:63618

object_name: lung neoplasm


subject: CHEBI:63618

object_name: lung carcinoma


subject: CHEMBL.COMPOUND:CHEMBL3545247

object_name: Atopic rhinitis


subject: CHEMBL.COMPOUND:CHEMBL3545247

object_name: Allergic Rhinitis, CTCAE


subject: CHEBI:50885

subject_name: Fludrocortisone

object_name: Subarachnoid Hemorrhage, Aneurysmal


subject: GTOPDB:9310

subject_name: lirilumab

object_name: Advanced cancer


subject: UNII:S9XDI9W918

subject_name: LIRILUMAB


subject: UMLS:C3641620


subject: PUBCHEM.COMPOUND:20734893

subject_name: Fluticasone furoate

object_name: Chronic obstructive pulmonary disease of horses


subject: UNII:Z1HHM49K7O

subject_name: Napabucasin

object_name: pancreatic ductal adenocarcinoma


subject: PUBCHEM.COMPOUND:9848990

subject_name: BUPRENORPHINE

object_name: spinal disease


subject: CHEBI:4055

subject_name: Cytisine

object_name: history of alcohol use


subject: CHEBI:4055

object_name: HIV infection


subject: CHEBI:84500

subject_name: varenicline


subject: CHEBI:73044

subject_name: Lumiracoxib

object_name: rheumatoid arthritis


subject: UMLS:C4505397

subject_name: Monovalent Influenza Vaccines

object_name: influenza


subject: UNII:QMS40680K6

subject_name: Palifermin

object_name: Primary malignant neoplasm


subject: UNII:QMS40680K6

object_name: cancer


subject: UNII:QMS40680K6

object_name: childhood malignant neoplasm


subject: UNII:QMS40680K6

object_name: Malignant obstetric neoplasm


subject: CHEBI:31528

subject_name: Ebastine

object_name: urticaria


subject: CHEBI:31528

object_name: reported urticaria (physical finding)


subject: CHEBI:31528

object_name: Urticaria, CTCAE


subject: CHEBI:5050

subject_name: Fexofenadine


subject: CHEBI:5050


subject: CHEBI:5050


subject: UNII:UT99UG9QJX

subject_name: Eflapegrastim

object_name: Solid Neoplasm


subject: UNII:UT99UG9QJX

object_name: adult lymphoma


subject: UNII:UT99UG9QJX

object_name: lymphoma


subject: UNII:UT99UG9QJX

object_name: pediatric lymphoma


subject: PUBCHEM.COMPOUND:118110201

object_name: Childhood Solid Neoplasm


subject: PUBCHEM.COMPOUND:118110201

object_name: Adult Solid Neoplasm


subject: PUBCHEM.COMPOUND:118110201


subject: UNII:DSP7A26K25


subject: UNII:DSP7A26K25


subject: UNII:DSP7A26K25


subject: UNII:TWF0ML1CK8

subject_name: Fluzoparib

object_name: kidney failure


subject: CHEBI:10023

subject_name: Voriconazole

object_name: Adverse drug response


subject: UMLS:C3530089

object_name: heart failure


subject: UMLS:C3530089

object_name: congestive heart failure


subject: CHEBI:168396

subject_name: Mycophenolic acid

object_name: age-related macular degeneration


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:82960

subject_name: Raltegravir

object_name: coronary microvascular disorder


subject: CHEBI:136048

subject_name: Vonoprazan

object_name: Delayed Graft Function


subject: PR:000015811

subject_name: succinate--CoA ligase [ADP-forming] subunit beta, mitochondrial

object_name: anal fistula


subject: PR:000015811

object_name: Anal Fistula, CTCAE


subject: UMLS:C0016004

subject_name: Beriplast P


subject: UMLS:C0016004


subject: GTOPDB:10350

subject_name: tibulizumab

object_name: Primary Sjögren's syndrome


subject: UNII:42HQ15W1ZF

subject_name: TIBULIZUMAB


subject: UMLS:C4726852

subject_name: Tibulizumab


subject: DRUGBANK:DB18235

object_name: Huntington disease


subject: UNII:09OB3E5QTD

object_name: Childhood Breast Carcinoma


subject: UNII:09OB3E5QTD

object_name: breast carcinoma


subject: UNII:09OB3E5QTD

object_name: breast cancer


subject: UMLS:C3886555


subject: UMLS:C3886555


subject: UMLS:C3886555


subject: UMLS:C4053648

subject_name: EC-18 cpd

object_name: Chemotherapy induced neutropenia


subject: PUBCHEM.COMPOUND:23594367

subject_name: Boceprevir

object_name: HCV coinfection


subject: PUBCHEM.COMPOUND:23594367

object_name: HIV-1 infection


subject: UNII:G8RGG88B68

subject_name: Peginterferon alfa-2b


subject: UNII:G8RGG88B68


subject: UMLS:C5392712

object_name: kidney failure


subject: UMLS:C3474499

subject_name: Goji berry preparation


subject: CHEBI:74705

subject_name: Met-Leu

object_name: epilepsy


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: CHEBI:6129

subject_name: Ketorolac

object_name: Symptomatic irreversible pulpitis


subject: CHEBI:4953

subject_name: Exemestane

object_name: non-small cell lung carcinoma


subject: CHEBI:27082

subject_name: trehalose

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: CHEBI:27082

object_name: amyotrophic lateral sclerosis


subject: UNII:5730VNW22X

object_name: sarcopenia


subject: CHEBI:194095

subject_name: mitomycin C(1-)

object_name: metastatic colorectal cancer


subject: CHEBI:27504

subject_name: Mitomycin


subject: UMLS:C1831888

object_name: neuroendocrine neoplasm


subject: UMLS:C2987605

subject_name: dalotuzumab


subject: UNII:13H90KC831

subject_name: VIAGENPUMATUCEL-L


subject: UMLS:C4287741

subject_name: Topoisomerase-1 Inhibitor LMP744

object_name: adult lymphoma


subject: UMLS:C4287741

object_name: lymphoma


subject: UMLS:C4287741

object_name: pediatric lymphoma


subject: UMLS:C4287741

object_name: Solid Neoplasm


subject: CHEBI:151315

subject_name: Heparin

object_name: Prevention problem


subject: UNII:E47C0NF7LV

subject_name: ENOXAPARIN


subject: UNII:8NZ41MIK1O

subject_name: Enoxaparin


subject: UMLS:C5418081

subject_name: BTK Inhibitor HZ-A-018

object_name: B-cell neoplasm


subject: UMLS:C5783498

subject_name: Aminolevulinic Acid Intravenous Formulation SONALA-001

object_name: High grade glioma


subject: UMLS:C5783498

object_name: malignant glioma


subject: CHEBI:30314

subject_name: Lipoic acid


subject: CHEBI:46217

subject_name: L-alanine residue


subject: CHEBI:158283

subject_name: Ala-Leu-Ala


subject: CHEBI:16449

subject_name: DL-Alanine


subject: CHEBI:43796

subject_name: (S)-lipoic acid


subject: CHEBI:27432

subject_name: linolenic acid


subject: CHEBI:16977

subject_name: Alanine


subject: UNII:E00MVC7O57

subject_name: Balicatib

object_name: osteoarthritis, knee


subject: UMLS:C2703149


subject: UMLS:C3864383

subject_name: Lumason

object_name: liver carcinoma


subject: UNII:9566855ULN

subject_name: ISOBUTAMBEN

object_name: no feeling or sensation of skin


subject: UNII:9566855ULN

object_name: Sensory Loss


subject: UNII:9566855ULN

object_name: Surgical procedure finding


subject: UMLS:C4316877

subject_name: Scandicaine


subject: UMLS:C4316877


subject: UMLS:C4316877


subject: CHEBI:6759

subject_name: Mepivacaine


subject: CHEBI:8665

subject_name: Pyridostigmine

object_name: long COVID-19


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: Anticoagulants and Bleeding Disorders


subject: CHEBI:52763

object_name: cancer


subject: CHEBI:52763

object_name: neoplasm


subject: UMLS:C3864383

object_name: heart disorder


subject: CHEBI:6149

subject_name: Levobupivacaine

object_name: chronic pain (diagnosis)


subject: CHEBI:6149

object_name: Chronic pain


subject: CHEBI:6149

object_name: Acute Pain


subject: UMLS:C5552626

subject_name: Mineralocorticoid Receptor Antagonist [EPC]

object_name: Conn's syndrome


subject: CHEBI:72317

subject_name: Cabozantinib

object_name: Metastatic malignant neoplasm to pancreas


subject: UNII:0Y70779M1F

subject_name: Botulinum toxin type B

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: UNII:0Y70779M1F

object_name: amyotrophic lateral sclerosis


subject: UMLS:C0006051


subject: UMLS:C0006051


subject: MESH:C568859

object_name: OPTN-related open angle glaucoma


subject: UMLS:C4725178

subject_name: TAFIa Inhibitor DS-1040b

object_name: Drug Interactions


subject: UMLS:C4725178

object_name: Adverse drug interaction


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: rectum adenocarcinoma


subject: CHEBI:43871

subject_name: Fasudil

object_name: corticobasal syndrome


subject: CHEBI:43871

object_name: corticobasal degeneration disorder


subject: CHEBI:43871

object_name: progressive supranuclear palsy


subject: UMLS:C4722843

subject_name: Eflornithine Hydrochloride Cream

object_name: Melasma


subject: CHEBI:17594

subject_name: Hydroquinone


subject: UNII:37KZM6S21G

subject_name: cerebrolysin

object_name: Traumatic AND/OR non-traumatic brain injury


subject: UNII:37KZM6S21G

object_name: brain injury


subject: UNII:37KZM6S21G

object_name: cognitive disorder


subject: UNII:37KZM6S21G

object_name: Surgery--Complications


subject: UNII:37KZM6S21G

object_name: Critical Illness


subject: UNII:37KZM6S21G

object_name: heart disorder


subject: UMLS:C0055108


subject: UMLS:C0055108


subject: UMLS:C0055108


subject: UMLS:C0055108


subject: UMLS:C0055108


subject: UMLS:C0055108


subject: CHEBI:28787

subject_name: Nitroglycerin

object_name: non-small cell lung carcinoma


subject: CHEBI:28787

object_name: metastatic malignant neoplasm in the brain


subject: CHEBI:28787

object_name: EGFR gene mutation


subject: CHEBI:23580

subject_name: decyl group

object_name: strongyloidiasis


subject: CHEBI:23580

object_name: scabies


subject: CHEBI:23574

subject_name: decanoyl group


subject: CHEBI:23574


subject: CHEBI:16664

subject_name: Albendazole


subject: CHEBI:16664


subject: UNII:885H5YC40L

subject_name: levamlodipine besylate

object_name: essential hypertension


subject: PUBCHEM.COMPOUND:54675783

subject_name: minocycline

object_name: uveitis


subject: PUBCHEM.COMPOUND:54675783

object_name: Uveitis, CTCAE


subject: PUBCHEM.COMPOUND:54675783

object_name: retinal degeneration


subject: CHEBI:50513

subject_name: mydriatic agent

object_name: age-related macular degeneration


subject: CHEBI:50513

object_name: glaucoma


subject: CHEBI:50513

object_name: Glaucoma, CTCAE


subject: CHEBI:50513

object_name: eye disorder


subject: CHEBI:50513

object_name: retinal vein occlusion


subject: UMLS:C0026964

subject_name: Mydriatics


subject: UMLS:C0026964


subject: UMLS:C0026964


subject: UMLS:C0026964


subject: UMLS:C0026964


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin

object_name: Gastroesophageal junction cancer


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: CHEBI:31348

subject_name: Capecitabine


subject: CHEBI:135810

subject_name: Atrasentan

object_name: coronary microvascular disorder


subject: UMLS:C2348411

object_name: unspecified adult solid tumor, protocol specific


subject: UMLS:C2348411

object_name: small intestine cancer


subject: UMLS:C2348411

object_name: small intestine carcinoma


subject: UMLS:C2348411

object_name: lymphoproliferative syndrome


subject: PUBCHEM.COMPOUND:66586232

object_name: Dental Plaque


subject: UMLS:C4053649

subject_name: WT1 Protein-derived Peptide Vaccine DSP-7888

object_name: Acute myeloid leukemia in remission


subject: GTOPDB:12347

subject_name: penpulimab

object_name: Childhood Breast Carcinoma


subject: GTOPDB:12347

object_name: breast carcinoma


subject: GTOPDB:12347

object_name: breast cancer


subject: CHEMBL.COMPOUND:CHEMBL4297571

subject_name: PENPULIMAB


subject: CHEMBL.COMPOUND:CHEMBL4297571


subject: CHEMBL.COMPOUND:CHEMBL4297571


subject: UMLS:C4723695


subject: UMLS:C4723695


subject: UMLS:C4723695


subject: UMLS:C2010383

subject_name: intravenous gamma globulin

object_name: chronic inflammatory demyelinating polyradiculoneuropathy


subject: CHEBI:18315

subject_name: PQQ Cofactor

object_name: Inflammation


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: Stage II Nasopharyngeal Carcinoma AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IV Nasopharyngeal Carcinoma AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage III Nasopharyngeal Carcinoma AJCC v8


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C5907950

subject_name: Anti-CD147 Monoclonal Antibody DS-1471

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C5848866

subject_name: Immunotherapy [APC]

object_name: gastroparesis


subject: UMLS:C5848866

object_name: Gastroparesis, CTCAE


subject: UMLS:C0939333

subject_name: Estradiol Patch

object_name: Menopause present (finding)


subject: UMLS:C0939333

object_name: Menopause


subject: UMLS:C0939333

object_name: Irritability


subject: CHEBI:17026

subject_name: Progesterone


subject: CHEBI:91985

subject_name: nadolol

object_name: asthma


subject: PUBCHEM.COMPOUND:14794883

subject_name: Folerogenin


subject: UNII:37CQ2C7X93

subject_name: Canakinumab

object_name: Clonal Cytopenia of Undetermined Significance


subject: UMLS:C2718754

subject_name: Ilaris


subject: CHEBI:231679

subject_name: ipilimumab

object_name: tumor suppressor gene on chromosome 11


subject: MESH:C039984

subject_name: Bretschneider cardioplegic solution

object_name: Myocardial injury


subject: UMLS:C0150765

subject_name: Shampoo (substance)

object_name: severe acute respiratory syndrome


subject: UMLS:C0150765


subject: CHEBI:28741

subject_name: Sodium fluoride


subject: CHEBI:28741


subject: CHEBI:6121

subject_name: Ketamine

object_name: Surgical procedure, unspecified


subject: CHEBI:44915

subject_name: Propofol


subject: CHEBI:6456

subject_name: Lidocaine


subject: CHEBI:74705

subject_name: Met-Leu

object_name: toothache


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: UMLS:C0141582

subject_name: saruplase

object_name: ST-segment elevation myocardial infarction (STEMI)


subject: CHEBI:2469

subject_name: Adefovir

object_name: fibrosis


subject: UNII:2N4O9L084N

subject_name: Nabilone

object_name: Anorexia


subject: UNII:2N4O9L084N

object_name: Anorexia, CTCAE


subject: UNII:2N4O9L084N

object_name: Anorexia symptom


subject: UNII:2N4O9L084N

object_name: non-small cell lung carcinoma


subject: UNII:2N4O9L084N

object_name: Cachexia


subject: UNII:2N4O9L084N

object_name: Weight loss


subject: UNII:2N4O9L084N

object_name: Lose weight


subject: CHEBI:36796

subject_name: duloxetine

object_name: Childhood Solid Neoplasm


subject: CHEBI:36796

object_name: Adult Solid Neoplasm


subject: CHEBI:36796

object_name: Peripheral neuropathy due to and following antineoplastic therapy


subject: UNII:5V51S7839P

object_name: rhizomelic chondrodysplasia punctata


subject: UMLS:C2827670


subject: PUBCHEM.COMPOUND:131751553

subject_name: Morellinol

object_name: Decreased circulating vitamin E concentration


subject: PUBCHEM.COMPOUND:131751553

object_name: short bowel syndrome


subject: CHEBI:176233

subject_name: Tocophersolan


subject: CHEBI:176233


subject: CHEBI:18145

subject_name: Vitamin E


subject: UNII:O03S90U1F2

subject_name: Tocofersolan


subject: UNII:O03S90U1F2


subject: UMLS:C5204561

object_name: plasma cell myeloma


subject: CHEBI:83766

subject_name: Olaparib

object_name: Advanced Paraganglioma


subject: CHEBI:83766

object_name: Unresectable Paraganglioma


subject: CHEBI:83766

object_name: Malignant Paraganglioma


subject: CHEBI:83766

object_name: Unresectable Adrenal Gland Pheochromocytoma


subject: CHEBI:83766

object_name: malignant adrenal gland pheochromocytoma


subject: CHEBI:83766

object_name: Advanced Adrenal Gland Pheochromocytoma


subject: CHEBI:83766

object_name: Stage IV Adrenal Gland Pheochromocytoma and Sympathetic Paraganglioma AJCC v8


subject: CHEBI:83766

object_name: Stage III Adrenal Gland Pheochromocytoma and Sympathetic Paraganglioma AJCC v8


subject: UMLS:C4733471

object_name: non-Hodgkin lymphoma


subject: UNII:LVI5P34A3C

subject_name: FLUOROESTRADIOL

object_name: Carcinoma breast stage IV


subject: CHEBI:36939

subject_name: Fluorine F-18


subject: UMLS:C3641862

object_name: acute myeloid leukemia


subject: UMLS:C3641862

object_name: Myelodysplasia


subject: UMLS:C3641862

object_name: Adult Myelodysplastic Syndrome


subject: UMLS:C3641862

object_name: childhood myelodysplastic syndrome


subject: UMLS:C3641862

object_name: Myelodysplastic Syndrome, CTCAE


subject: CHEBI:31300

subject_name: BOSENTAN

object_name: Functional single ventricle


subject: CHEBI:51450

subject_name: Bosentan


subject: UNII:N5UK68MGDZ

subject_name: Apremilast

object_name: lichen planus, oral


subject: CHEBI:100241

subject_name: Ciprofloxacin

object_name: BK virus infection


subject: CHEBI:29998

subject_name: D-serine residue

object_name: tardive dyskinesia


subject: CHEBI:17115

subject_name: Serine


subject: UMLS:C1880218

subject_name: serine, D-


subject: CHEBI:231347

subject_name: Triapine

object_name: Non-small cell lung cancer recurrent


subject: UMLS:C0723460

subject_name: Stress bismuth subsalicylate

object_name: irritable bowel syndrome


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: aortic valve disease 2


subject: UMLS:C0013227

object_name: aortic stenosis


subject: UMLS:C0013227

object_name: aortic valve disease 3


subject: UMLS:C0013227

object_name: Stenosis of aorta


subject: UMLS:C0013227

object_name: aortic valve calcification


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: UMLS:C1254351


subject: UMLS:C1254351


subject: UMLS:C1254351


subject: UMLS:C1254351


subject: CHEBI:8228

subject_name: Pioglitazone


subject: CHEBI:8228


subject: CHEBI:8228


subject: CHEBI:8228


subject: CHEBI:8228


subject: CHEBI:50733

subject_name: nutraceutical

object_name: mood (physical finding)


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: Cirrhosis


subject: CHEBI:39548

object_name: liver cirrhosis


subject: CHEBI:39548

object_name: Decompensated cirrhosis of liver


subject: CHEBI:135926

subject_name: Udenafil

object_name: Mild pulmonary hypertension


subject: UMLS:C2349009

subject_name: Zydena


subject: HMDB:HMDB0001349

subject_name: Selenium

object_name: subarachnoid hemorrhage


subject: HMDB:HMDB0001349

object_name: Physical trauma


subject: HMDB:HMDB0001349

object_name: Injury


subject: HMDB:HMDB0001349

object_name: Trauma


subject: UMLS:C0521939

subject_name: Selenium supplement


subject: UMLS:C0521939


subject: UMLS:C0521939


subject: UMLS:C0521939


subject: CHEBI:74813

subject_name: Ser-Glu


subject: CHEBI:74813


subject: CHEBI:74813


subject: CHEBI:74813


subject: PR:000015601

subject_name: squalene monooxygenase


subject: PR:000015601


subject: PR:000015601


subject: PR:000015601


subject: PR:000007705


subject: PR:000007705


subject: PR:000007705


subject: PR:000007705


subject: UMLS:C2348288

subject_name: Dietary Zinc


subject: UMLS:C2348288


subject: UMLS:C2348288


subject: UMLS:C2348288


subject: CHEBI:29105

subject_name: Velmanase alfa


subject: CHEBI:29105


subject: CHEBI:29105


subject: CHEBI:29105


subject: CHEBI:27363

subject_name: Zinc


subject: CHEBI:27363


subject: CHEBI:27363


subject: CHEBI:27363


subject: UMLS:C3541396

subject_name: Zinc Supplements


subject: UMLS:C3541396


subject: UMLS:C3541396


subject: UMLS:C3541396


subject: UMLS:C3714650

subject_name: Zinc Drug Class


subject: UMLS:C3714650


subject: UMLS:C3714650


subject: UMLS:C3714650


subject: CHEBI:38290

subject_name: L-ascorbate


subject: CHEBI:38290


subject: CHEBI:38290


subject: CHEBI:176783

subject_name: vitamin C


subject: CHEBI:176783


subject: CHEBI:176783


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C3714687


subject: UMLS:C3714687


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: UMLS:C2349136


subject: UMLS:C2349136


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: UMLS:C4522080


subject: UMLS:C4522080


subject: CHEBI:33283

subject_name: THIAMINE


subject: CHEBI:33283


subject: CHEBI:33283


subject: CHEBI:33283


subject: CHEBI:18385

subject_name: Thiamine


subject: CHEBI:18385


subject: CHEBI:18385


subject: CHEBI:18385


subject: UMLS:C3714803

subject_name: Vitamin E Drug Class


subject: UMLS:C3714803


subject: UMLS:C3714803


subject: UMLS:C3714803


subject: CHEMBL.COMPOUND:CHEMBL3989727

subject_name: VITAMIN E


subject: CHEMBL.COMPOUND:CHEMBL3989727


subject: CHEMBL.COMPOUND:CHEMBL3989727


subject: CHEMBL.COMPOUND:CHEMBL3989727


subject: CHEBI:18145

subject_name: Vitamin E


subject: CHEBI:18145


subject: CHEBI:18145


subject: CHEBI:18145


subject: CHEBI:93775

subject_name: Amethopterin

object_name: endocrine exophthalmos


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: PUBCHEM.COMPOUND:155543961

subject_name: LIRAGLUTIDE

object_name: infertility


subject: UMLS:C1099192


subject: UMLS:C5417883

subject_name: CYP11A1 Inhibitor ODM-209

object_name: castration-resistant prostate carcinoma


subject: UMLS:C5417883

object_name: Advanced breast cancer


subject: UMLS:C5417883

object_name: metastatic prostate carcinoma


subject: UMLS:C5417883

object_name: Carcinoma breast stage IV


subject: CHEBI:50648

subject_name: Alitretinoin

object_name: cutaneous lupus erythematosus


subject: PUBCHEM.COMPOUND:134506

subject_name: Dehydroandrosterone


subject: PUBCHEM.COMPOUND:134506

object_name: estrogen-receptor positive breast cancer


subject: PUBCHEM.COMPOUND:134506

object_name: Progesterone receptor positive tumor


subject: PUBCHEM.COMPOUND:134506

object_name: Androgen receptor gene overexpression


subject: PUBCHEM.COMPOUND:134506

object_name: Estrogen receptor negative neoplasm


subject: PUBCHEM.COMPOUND:134506

object_name: Progesterone receptor negative neoplasm


subject: CHEBI:85252

subject_name: synaptamide


subject: CHEBI:85252


subject: CHEBI:85252


subject: CHEBI:85252


subject: CHEBI:85252


subject: CHEBI:85252


subject: CHEBI:89608

subject_name: Cervonoyl ethanolamide


subject: CHEBI:89608


subject: CHEBI:89608


subject: CHEBI:89608


subject: CHEBI:89608


subject: CHEBI:89608


subject: CHEBI:28689

subject_name: Prasterone


subject: CHEBI:28689


subject: CHEBI:28689


subject: CHEBI:28689


subject: CHEBI:28689


subject: CHEBI:28689


subject: CHEBI:119915

subject_name: Fentanyl

object_name: Headache


subject: UNII:Q1IF8M2YL3

subject_name: Ozarelix

object_name: prostate carcinoma


subject: UNII:Q1IF8M2YL3

object_name: prostate cancer


subject: CHEMBL.COMPOUND:CHEMBL2108312

subject_name: OZARELIX


subject: CHEMBL.COMPOUND:CHEMBL2108312


subject: UMLS:C2987000

subject_name: ozarelix


subject: UMLS:C2987000


subject: UMLS:C0384570

subject_name: Recombinant Human Growth Hormone

object_name: achondroplasia


subject: UMLS:C2825029

subject_name: Recombinant Human Growth Hormone [EPC]


subject: UMLS:C4282332

object_name: acute lymphoblastic leukemia


subject: UMLS:C4282332

object_name: recurrent adult acute myeloid leukemia


subject: CHEBI:150712

subject_name: Hyaluronic acid

object_name: Temporomandibular joint disc displacement


subject: CHEMBL.COMPOUND:CHEMBL5314376

subject_name: HYALURONIC ACID


subject: CHEBI:231347

subject_name: Triapine

object_name: pancreatic neoplasm


subject: CHEBI:231347

object_name: exocrine pancreatic carcinoma


subject: CHEBI:231347

object_name: malignant pancreatic neoplasm


subject: CHEBI:74947

subject_name: Thalidomide

object_name: coronary artery disorder


subject: CHEBI:74947

object_name: coronary atherosclerosis


subject: CHEBI:74705

subject_name: Met-Leu

object_name: rabies


subject: CHEBI:74705

object_name: Human rabies


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000009425


subject: PR:000016318

subject_name: thrombopoietin


subject: PR:000016318


subject: UMLS:C0009905

subject_name: Contraceptives, Oral

object_name: Endometrioma


subject: UMLS:C0009905

object_name: ovarian reserve


subject: CHEMBL.COMPOUND:CHEMBL4297681

object_name: SLE glomerulonephritis syndrome, WHO class III


subject: CHEMBL.COMPOUND:CHEMBL4297681

object_name: SLE glomerulonephritis syndrome, WHO class IV


subject: CHEMBL.COMPOUND:CHEMBL4297681

object_name: st. Louis encephalitis


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4026


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:63599


subject: UNII:O43472U9X8

subject_name: Obinutuzumab


subject: UNII:O43472U9X8


subject: UNII:O43472U9X8


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C4742319

subject_name: Yangxinshi tablet

object_name: Cardiac dysfunction


subject: UMLS:C4742319


subject: CHEBI:81045

subject_name: lead oxide

object_name: Hypercholesterolemia


subject: CHEBI:53450

subject_name: poly(butylene oxide) macromolecule


subject: CHEBI:61603

subject_name: poly(butylene oxide) polymer


subject: CHEBI:32687

subject_name: Piperonyl butoxide


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: B-cell non-Hodgkin lymphoma


subject: CHEBI:229764

subject_name: Selinexor


subject: CHEBI:229764

object_name: B-cell neoplasm


subject: UMLS:C4764354

subject_name: Niagen

object_name: Diabetic peripheral neuropathy


subject: PUBCHEM.COMPOUND:9296

subject_name: treosulfan

object_name: inborn errors of metabolism


subject: PUBCHEM.COMPOUND:9296

object_name: inborn error of immunity


subject: PUBCHEM.COMPOUND:9296

object_name: hemoglobinopathy


subject: DRUGBANK:DB17293

subject_name: Hiltonol

object_name: neoplasm


subject: UNII:7KYP9TKT70

subject_name: poly ICLC


subject: CHEBI:135207

subject_name: Clofedanol

object_name: Critical Illness


subject: CHEBI:15365

subject_name: Aspirin


subject: CHEBI:68558

subject_name: Ticagrelor


subject: MESH:D014131

subject_name: Trace Elements

object_name: tuberculosis


subject: UMLS:C0282575

subject_name: Micronutrients


subject: UMLS:C2348288

subject_name: Dietary Zinc


subject: CHEBI:29105

subject_name: Velmanase alfa


subject: UMLS:C3541396

subject_name: Zinc Supplements


subject: UMLS:C3714650

subject_name: Zinc Drug Class


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: systemic inflammatory response syndrome


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: Hypoventilation


subject: CHEBI:46195

object_name: sleep apnea


subject: CHEBI:46195

object_name: Postoperative Complications


subject: CHEBI:46195

object_name: Obstructive sleep apnea of child


subject: CHEBI:46195

object_name: Pathologic Processes


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: UMLS:C2917659


subject: UMLS:C2917659


subject: UMLS:C2917659


subject: UMLS:C2917659


subject: CHEBI:42797

subject_name: Gabapentin


subject: CHEBI:42797


subject: CHEBI:42797


subject: CHEBI:42797


subject: CHEBI:6121

subject_name: Ketamine


subject: CHEBI:6121


subject: CHEBI:6456

subject_name: Lidocaine


subject: CHEBI:6456


subject: CHEBI:6456


subject: CHEBI:6456


subject: CHEBI:6456


subject: CHEBI:4466

subject_name: Dexmedetomidine


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:7N8K34P2XH


subject: CHEBI:9130

subject_name: Sevoflurane


subject: CHEBI:9130


subject: CHEBI:9130


subject: CHEBI:9130


subject: CHEBI:84094

subject_name: testosterone sulfate

object_name: Alzheimer disease


subject: CHEBI:17347

subject_name: Testosterone


subject: CHEBI:42797

object_name: Radiation neuropathy


subject: UMLS:C0935876

object_name: malignant soft tissue neoplasm


subject: UMLS:C0935876

object_name: sarcoma


subject: CHEBI:6904

subject_name: Metoprolol

object_name: anterolateral myocardial infarction


subject: CHEBI:7454

subject_name: Nalbuphine

object_name: Acute Pain


subject: CHEBI:9150

subject_name: Simvastatin

object_name: Severe asthma


subject: UMLS:C0694951

subject_name: INJECTION, AMPHOTERICIN B, 50 MG ADMINISTERED

object_name: esophageal candidiasis


subject: CHEBI:2682

subject_name: Amphotericin B


subject: UMLS:C3640058

subject_name: Asparec

object_name: hematopoietic and lymphoid system neoplasm


subject: MESH:C558652

object_name: leukemia


subject: MESH:C558652

object_name: childhood leukemia


subject: CHEBI:204928

subject_name: Cefotaxime

object_name: peritonitis


subject: CHEBI:29007

subject_name: Ceftriaxone

object_name: Primary bacterial peritonitis


subject: UNII:3K3KYC9LES

object_name: childhood neoplasm


subject: UNII:3K3KYC9LES

object_name: neoplastic syndrome


subject: UNII:3K3KYC9LES

object_name: cancer or benign tumor


subject: UNII:3K3KYC9LES

object_name: neoplasm


subject: MESH:C562231


subject: MESH:C562231


subject: MESH:C562231


subject: MESH:C562231


subject: CHEBI:36121

subject_name: flavylium

object_name: Inflammation of mouth


subject: CHEBI:36121

object_name: stomatitis


subject: CHEBI:36121

object_name: Acute mucous inflammation


subject: CHEBI:71940

subject_name: Tadalafil

object_name: endogenous depression


subject: CHEBI:71940

object_name: major depressive disorder


subject: UNII:K911R84KEW

subject_name: Margetuximab


subject: UNII:K911R84KEW

object_name: head and neck squamous cell carcinoma


subject: UNII:K911R84KEW

object_name: triple-negative breast carcinoma


subject: UNII:K911R84KEW

object_name: non-small cell lung carcinoma


subject: UNII:K911R84KEW

object_name: cholangiocarcinoma


subject: UNII:K911R84KEW

object_name: cervical cancer


subject: UNII:K911R84KEW

object_name: cervical carcinoma


subject: UNII:K911R84KEW

object_name: ovarian cancer


subject: UNII:K911R84KEW

object_name: ovarian neoplasm


subject: UNII:K911R84KEW

object_name: ovarian carcinoma


subject: UMLS:C2984521

subject_name: MGAH22 antibody

object_name: hematopoietic and lymphoid system neoplasm


subject: UMLS:C2984521


subject: UMLS:C2984521


subject: UMLS:C2984521


subject: UMLS:C2984521


subject: UMLS:C2984521


subject: UMLS:C2984521


subject: UMLS:C2984521


subject: UMLS:C2984521


subject: UMLS:C2984521


subject: CHEBI:49140

object_name: Disseminated Malignant Neoplasm


subject: CHEBI:49140

object_name: Embolism, Tumor


subject: CHEBI:49140

object_name: Neoplasm Metastasis


subject: CHEBI:49134


subject: CHEBI:49134


subject: CHEBI:49134


subject: CHEBI:31617

subject_name: fludeoxyglucose (18F)


subject: CHEBI:31617


subject: CHEBI:31617


subject: CHEBI:38940

subject_name: Sunitinib

object_name: thymoma


subject: CHEBI:38940

object_name: thymus neoplasm


subject: UMLS:C5963570

subject_name: KRAS G12D Inhibitor AZD0022


subject: UMLS:C5963570

object_name: pancreatic ductal adenocarcinoma


subject: PUBCHEM.COMPOUND:44573417

subject_name: METFORMIN XR

object_name: Childhood Breast Carcinoma


subject: PUBCHEM.COMPOUND:44573417

object_name: breast carcinoma


subject: PUBCHEM.COMPOUND:44573417

object_name: breast cancer


subject: PUBCHEM.COMPOUND:3043660


subject: PUBCHEM.COMPOUND:3043660


subject: PUBCHEM.COMPOUND:3043660


subject: UMLS:C1963284

subject_name: Adrenalin

object_name: Post-Operative Pain


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: BRCA1 gene mutation


subject: CHEBI:31355

subject_name: Carboplatin

object_name: pancreatic acinar cell carcinoma


subject: CHEBI:72317

subject_name: Cabozantinib

object_name: Pancreatic adenocarcinoma metastatic


subject: CHEBI:41948

subject_name: Eflornithine

object_name: cervical cancer


subject: CHEBI:41948

object_name: cervical carcinoma


subject: CHEBI:57986

object_name: Myalgia


subject: UMLS:C3714502

subject_name: Riboflavin Drug Class


subject: CHEBI:17621

subject_name: FMN


subject: CHEBI:17015

subject_name: Riboflavin


subject: PUBCHEM.COMPOUND:3384

subject_name: Fluoromethalone

object_name: bullous keratopathy


subject: PUBCHEM.COMPOUND:3384

object_name: Corneal epithelial edema


subject: PUBCHEM.COMPOUND:3384

object_name: corneal dystrophy, Fuchs endothelial, 1


subject: PUBCHEM.COMPOUND:3384

object_name: Fuchs' endothelial dystrophy


subject: CHEBI:31625

subject_name: Fluorometholone


subject: CHEBI:31625


subject: CHEBI:31625


subject: CHEBI:31625


subject: PUBCHEM.COMPOUND:4895

subject_name: Pred Forte


subject: PUBCHEM.COMPOUND:4895


subject: PUBCHEM.COMPOUND:4895


subject: PUBCHEM.COMPOUND:4895


subject: CHEBI:8378

subject_name: Prednisolone


subject: CHEBI:8378


subject: CHEBI:8378


subject: CHEBI:8378


subject: UMLS:C1831888

object_name: non-small cell lung carcinoma


subject: CHEBI:131389

subject_name: magnesium citrate

object_name: abdominal obesity-metabolic syndrome


subject: CHEBI:131389

object_name: metabolic syndrome X


subject: CHEBI:131389

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:131389

object_name: obesity


subject: CHEBI:131389

object_name: Obesity, CTCAE


subject: CHEBI:131391


subject: CHEBI:131391


subject: CHEBI:131391


subject: CHEBI:131391


subject: CHEBI:131391


subject: UNII:98DE7VN88D

subject_name: huMov 19

object_name: neoplasm


subject: UMLS:C3640818


subject: PUBCHEM.COMPOUND:135415564

subject_name: Rifabutin

object_name: staphylococcus aureus infection


subject: CHEBI:45367


subject: UMLS:C0678449

subject_name: Cannabis substance

object_name: spinal cord injury


subject: UMLS:C0024808

subject_name: Marihuana


subject: UMLS:C4552088

subject_name: Cannabis sativa whole extract


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: mortality


subject: CHEBI:94518

object_name: Upper gastrointestinal hemorrhage


subject: CHEMBL.COMPOUND:CHEMBL4297877

subject_name: BALSTILIMAB

object_name: Resectable Colorectal Carcinoma


subject: UMLS:C4526708


subject: CHEMBL.COMPOUND:CHEMBL4650435

subject_name: BOTENSILIMAB


subject: UMLS:C4764272

subject_name: Botensilimab


subject: UNII:28X28X9OKV

subject_name: Durvalumab


subject: UMLS:C3641122


subject: CHEBI:231614

subject_name: Nivolumab


subject: UMLS:C2346820


subject: UNII:6A901E312A

subject_name: Panitumumab


subject: CHEBI:178199

subject_name: Sotorasib

object_name: colorectal cancer


subject: CHEBI:178199

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:178199


subject: UNII:SE2KH7T06F


subject: UMLS:C4287766


subject: UMLS:C4287766

object_name: colorectal carcinoma


subject: UMLS:C4287766


subject: UMLS:C4287766


subject: UMLS:C5908098

subject_name: Vorbipiprant


subject: UMLS:C5908098


subject: UMLS:C5908098


subject: UMLS:C5908098


subject: PUBCHEM.COMPOUND:133081958


subject: PUBCHEM.COMPOUND:133081958


subject: PUBCHEM.COMPOUND:133081958


subject: PUBCHEM.COMPOUND:133081958


subject: PUBCHEM.COMPOUND:147912

subject_name: Posaconazole

object_name: Chagas disease


subject: PUBCHEM.COMPOUND:450601

subject_name: Fluciclovine (18F)

object_name: cervical cancer


subject: PUBCHEM.COMPOUND:450601

object_name: cervical carcinoma


subject: PUBCHEM.COMPOUND:450601

object_name: uterine cancer


subject: PUBCHEM.COMPOUND:450601

object_name: tumor of uterus


subject: PUBCHEM.COMPOUND:10820564

subject_name: Fluciclovine


subject: PUBCHEM.COMPOUND:10820564


subject: PUBCHEM.COMPOUND:10820564


subject: PUBCHEM.COMPOUND:10820564


subject: CHEBI:134703


subject: CHEBI:134703


subject: PUBCHEM.COMPOUND:92043599

subject_name: epoetin alfa

object_name: anemia as adverse effect of chemotherapeutics


subject: CHEBI:81579

subject_name: Erythropoietin


subject: UMLS:C1579319

subject_name: pneumococcal conjugate vaccine

object_name: rheumatoid arthritis


subject: UMLS:C0305065

subject_name: Polyvalent pneumococcal vaccine


subject: UNII:OL741S3N8B

subject_name: irinotecan sucrosofate

object_name: Borderline Resectable Pancreatic Ductal Adenocarcinoma


subject: PUBCHEM.COMPOUND:4456137

subject_name: Epothilone B

object_name: peritoneal neoplasm


subject: PUBCHEM.COMPOUND:4456137

object_name: fallopian tube neoplasm


subject: PUBCHEM.COMPOUND:4456137

object_name: ovarian cancer


subject: PUBCHEM.COMPOUND:4456137

object_name: ovarian neoplasm


subject: CHEBI:31550

subject_name: Patupilone


subject: CHEBI:31550


subject: CHEBI:31550


subject: CHEBI:31550


subject: CHEBI:48814

subject_name: Chloral

object_name: Sedation


subject: CHEBI:48814

object_name: Sedated


subject: UNII:KXG2PJ551I

subject_name: Avelumab

object_name: digestive system neuroendocrine tumor, grade 1/2


subject: UNII:KXG2PJ551I

object_name: digestive system neuroendocrine neoplasm


subject: UNII:KXG2PJ551I

object_name: biliary tract cancer


subject: UNII:KXG2PJ551I

object_name: malignant pleural mesothelioma


subject: UNII:KXG2PJ551I

object_name: thyroid tumor


subject: UNII:KXG2PJ551I

object_name: thyroid gland carcinoma


subject: UNII:KXG2PJ551I

object_name: thyroid cancer


subject: UNII:KXG2PJ551I

object_name: Plexosarcoma


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: CHEBI:68646

subject_name: REGORAFENIB


subject: CHEBI:68646


subject: CHEBI:68646

object_name: triple-negative breast carcinoma


subject: CHEBI:68646

object_name: Triple-Negative Breast Cancer Finding


subject: CHEBI:68646


subject: CHEBI:68646


subject: CHEBI:68646

object_name: HPV-related carcinoma


subject: CHEBI:68646

object_name: Childhood Soft Tissue Sarcoma


subject: CHEBI:68646

object_name: Adult Soft Tissue Sarcoma


subject: CHEBI:68646

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: CHEBI:68646

object_name: soft tissue sarcoma


subject: CHEBI:68646

object_name: renal carcinoma


subject: CHEBI:68647

subject_name: Regorafenib


subject: CHEBI:68647


subject: CHEBI:68647


subject: CHEBI:68647


subject: CHEBI:68647


subject: CHEBI:68647


subject: CHEBI:68647


subject: CHEBI:68647


subject: CHEBI:68647


subject: CHEBI:68647


subject: CHEBI:68647


subject: CHEBI:68647


subject: CHEBI:22198

subject_name: acetylcysteine

object_name: Chronic obstructive pulmonary disease of horses


subject: CHEBI:22198

object_name: COPD, severe early onset


subject: CHEBI:17561

subject_name: Cysteine


subject: CHEBI:17561


subject: PUBCHEM.COMPOUND:21628493

subject_name: ESTROGEN

object_name: obesity due to melanocortin 4 receptor deficiency


subject: PUBCHEM.COMPOUND:21628493

object_name: obesity


subject: PUBCHEM.COMPOUND:21628493

object_name: Obesity, CTCAE


subject: CHEBI:50114

subject_name: estrogen


subject: CHEBI:50114


subject: CHEBI:50114


subject: CHEBI:4903

subject_name: Ethinylestradiol


subject: CHEBI:4903


subject: CHEBI:4903


subject: UMLS:C2936882

subject_name: Estrogen [EPC]


subject: UMLS:C2936882


subject: UMLS:C2936882


subject: CHEBI:17026

subject_name: Progesterone

object_name: obstructive sleep apnea syndrome


subject: CHEBI:17026


subject: CHEBI:17026


subject: CHEBI:17026


subject: UMLS:C2757070

subject_name: Progesterone [EPC]


subject: UMLS:C2757070


subject: UMLS:C2757070


subject: UMLS:C2757070


subject: CHEBI:24261

subject_name: glucocorticoid


subject: CHEBI:24261


subject: CHEBI:24261


subject: CHEBI:24261


subject: CHEBI:24261

object_name: Androgen excess


subject: CHEBI:84094

subject_name: testosterone sulfate


subject: CHEBI:84094


subject: UMLS:C4721537

subject_name: Therapeutic Testosterone


subject: UMLS:C4721537


subject: CHEBI:17347

subject_name: Testosterone


subject: CHEBI:17347


subject: CHEBI:229223

subject_name: Daprodustat

object_name: Tendon Injuries


subject: UMLS:C4043356


subject: UMLS:C1550506

subject_name: product - ParticipationType

object_name: vaginal disease


subject: UNII:0125DUV5XC

subject_name: varlilumab

object_name: glioblastoma


subject: UNII:0125DUV5XC

object_name: Childhood Glioblastoma


subject: UNII:0125DUV5XC

object_name: adult glioblastoma


subject: UMLS:C3274549


subject: UMLS:C3274549


subject: UMLS:C3274549


subject: UNII:N19A0T0E5J

subject_name: Parathyroid hormone

object_name: Trochanteric Fractures


subject: UMLS:C4255609

subject_name: Parathormone (human recombinant)

object_name: Fractured shoulder


subject: UMLS:C4255609


subject: UMLS:C5203423

subject_name: Nivolumab Liquid Injection

object_name: Malignant neoplasm of stomach stage IV


subject: UNII:FZ7NYF5N8L

subject_name: IRON SUCROSE

object_name: Surgical intervention (finding)


subject: UNII:FZ7NYF5N8L

object_name: Pelvis fracture


subject: UNII:FZ7NYF5N8L

object_name: Hip Fracture, CTCAE


subject: UNII:FZ7NYF5N8L

object_name: hip fracture


subject: CHEBI:192761

subject_name: Iron sucrose


subject: CHEBI:192761


subject: CHEBI:192761


subject: CHEBI:192761


subject: UMLS:C5959279

subject_name: Anti-CLDN6/CD3 Bispecific Antibody XmAb541

object_name: adult germ cell tumor


subject: UMLS:C5959279

object_name: germ cell tumor


subject: UMLS:C5959279

object_name: childhood germ cell tumor


subject: UMLS:C5959279

object_name: Germ Cell Cancer


subject: UMLS:C5959279

object_name: ovarian germ cell tumor


subject: UMLS:C5959279

object_name: pediatric ovarian germ cell tumor


subject: UMLS:C5959279

object_name: testicular germ cell tumor 1


subject: UMLS:C5959279

object_name: testicular germ cell tumor


subject: UMLS:C5959279

object_name: childhood testicular germ cell tumor


subject: UMLS:C5959279

object_name: endometrial cancer


subject: UMLS:C5959279

object_name: uterine corpus cancer


subject: UMLS:C5959279

object_name: endometrial carcinoma


subject: UMLS:C5959279

object_name: ovarian cancer


subject: UMLS:C5959279

object_name: ovarian neoplasm


subject: UMLS:C5959279

object_name: ovarian carcinoma


subject: UNII:X85G7936GV

subject_name: Abciximab

object_name: sickle cell disease


subject: UNII:X85G7936GV

object_name: Hb-SS disease with (vaso-occlusive) pain


subject: UNII:X85G7936GV

object_name: Hemoglobin SS disease with vasoocclusive crisis


subject: UNII:X85G7936GV

object_name: Hemoglobin SS disease with crisis


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: Central Nervous System Sensitization


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C3537249

subject_name: D Vitamin


subject: CHEBI:15365

subject_name: Aspirin

object_name: periodontitis, aggressive 1


subject: CHEBI:15365

object_name: acute pericementitis


subject: CHEBI:25681

subject_name: Omega-3 fatty acids


subject: CHEBI:25681


subject: CHEBI:233362

subject_name: Abemaciclib

object_name: Prognostic Stage II Breast Cancer AJCC v8


subject: CHEBI:233362

object_name: Prognostic Stage I Breast Cancer AJCC v8


subject: CHEBI:233362

object_name: Prognostic Stage IB Breast Cancer AJCC v8


subject: CHEBI:233362

object_name: Prognostic Stage IA Breast Cancer AJCC v8


subject: CHEBI:233362

object_name: Prognostic Stage III Breast Cancer AJCC v8


subject: CHEBI:233362

object_name: Prognostic Stage IIA Breast Cancer AJCC v8


subject: CHEBI:233362

object_name: Prognostic Stage IIB Breast Cancer AJCC v8


subject: CHEBI:233362

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:233362

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:233362

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:233362

object_name: ductal breast carcinoma in situ


subject: CHEBI:233362

object_name: lobular breast carcinoma in situ


subject: CHEBI:233362

object_name: breast fibrocystic disease


subject: UMLS:C5706420

subject_name: Oncolytic HSV-1 Expressing Anti-PD-1 scFv-Fc/TGFbRII Decoy/IL-12 STI-1386

object_name: Childhood Solid Neoplasm


subject: UMLS:C5706420

object_name: Adult Solid Neoplasm


subject: UMLS:C5706420

object_name: Solid Neoplasm


subject: UMLS:C5706420

object_name: Metastatic malignant neoplasm to liver


subject: UMLS:C5706420

object_name: pancreatic neoplasm


subject: UMLS:C5706420

object_name: exocrine pancreatic carcinoma


subject: UMLS:C5706420

object_name: malignant pancreatic neoplasm


subject: UMLS:C5706420

object_name: malignant soft tissue neoplasm


subject: UMLS:C5706420

object_name: sarcoma


subject: UMLS:C5706420

object_name: cancer


subject: UMLS:C5706420

object_name: neoplasm


subject: UNII:5S371K6132

subject_name: Rivoceranib

object_name: connective and soft tissue neoplasm


subject: UMLS:C4547969

subject_name: apatinib mesylate


subject: UMLS:C4547969


subject: UMLS:C4547969

object_name: Neck Carcinoma


subject: UMLS:C4547969

object_name: head and neck neoplasm


subject: UMLS:C4547969

object_name: head and neck cancer


subject: UMLS:C0599685

subject_name: Anti-Retroviral Agents

object_name: HIV infection


subject: CHEBI:88316

subject_name: Nefopam

object_name: gastric neoplasm


subject: CHEBI:8378

subject_name: Prednisolone

object_name: autoimmune hemolytic anemia


subject: PUBCHEM.COMPOUND:53025

subject_name: cefotetan

object_name: cholecystitis


subject: PUBCHEM.COMPOUND:53025

object_name: Cholecystitis, CTCAE 3.0


subject: PUBCHEM.COMPOUND:53025

object_name: Cholecystitis, CTCAE 5.0


subject: CHEBI:3499

subject_name: Cefotetan


subject: CHEBI:3499


subject: CHEBI:3499


subject: UNII:AF75XOF6W3

subject_name: Relatlimab

object_name: Stage III Cutaneous Melanoma AJCC v6


subject: UMLS:C3827149


subject: CHEBI:85155

subject_name: Netupitant

object_name: Primary malignant neoplasm


subject: CHEBI:85155


subject: CHEBI:85155

object_name: childhood malignant neoplasm


subject: CHEBI:85155

object_name: Malignant obstetric neoplasm


subject: UMLS:C5706298

subject_name: Ketone-IQ

object_name: Ketosis


subject: UMLS:C5706298

object_name: Ketoacidosis


subject: UMLS:C5706298

object_name: proteinuria


subject: UMLS:C5706298

object_name: Proteinuria of undiagnosed cause


subject: UMLS:C5706298

object_name: Proteinuria, CTCAE 3.0


subject: UMLS:C5706298

object_name: Proteinuria, CTCAE 5.0


subject: UMLS:C5706298

object_name: polycystic kidney disease


subject: UMLS:C5706298

object_name: Chronic uremia


subject: CHEBI:9144

subject_name: Silibinin

object_name: ulcerative colitis


subject: CHEBI:9144

object_name: inflammatory bowel disease 1


subject: CHEBI:125451

subject_name: silymarin


subject: CHEBI:125451


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: Proximal Femoral Fractures


subject: CHEBI:84363

object_name: Gestational diabetes mellitus in pregnancy


subject: CHEBI:2376

subject_name: acarbose


subject: CHEBI:8713

subject_name: Quinapril

object_name: type 2 diabetes mellitus


subject: CHEBI:8713

object_name: Diabetes


subject: CHEBI:30314

subject_name: Lipoic acid


subject: CHEBI:30314

object_name: diabetes mellitus


subject: CHEBI:43796

subject_name: (S)-lipoic acid

object_name: hypertension


subject: CHEBI:43796

object_name: Hypertension, CTCAE


subject: CHEBI:43796


subject: CHEBI:43796


subject: CHEBI:16494

subject_name: thioctic acid


subject: CHEBI:16494


subject: CHEBI:72317

subject_name: Cabozantinib

object_name: Gastrointestinal Carcinoid Tumor


subject: CHEBI:231614

subject_name: Nivolumab


subject: UMLS:C2346820


subject: UNII:63FJ7LF55O

object_name: Cough


subject: UNII:63FJ7LF55O

object_name: Cough, CTCAE


subject: CHEMBL.COMPOUND:CHEMBL3707225


subject: CHEMBL.COMPOUND:CHEMBL3707225


subject: UMLS:C1541350

subject_name: Falimarev

object_name: colorectal cancer


subject: UMLS:C1541350

object_name: colorectal carcinoma


subject: UMLS:C1541350

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C1541350

object_name: Disseminated Malignant Neoplasm


subject: UMLS:C1541350

object_name: Embolism, Tumor


subject: UMLS:C1541350

object_name: Neoplasm Metastasis


subject: UMLS:C1541349

subject_name: Inalimarev


subject: UMLS:C1541349


subject: UMLS:C1541349


subject: UMLS:C1541349


subject: UMLS:C1541349


subject: UMLS:C1541349


subject: UMLS:C4743107

object_name: abdominal obesity-metabolic syndrome


subject: UMLS:C4743107

object_name: metabolic syndrome X


subject: UMLS:C4743107

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UMLS:C4743107

object_name: obesity


subject: UMLS:C4743107

object_name: Obesity, CTCAE


subject: CHEBI:167574

subject_name: Semaglutide

object_name: Hyperplasia of the endometrium


subject: UMLS:C2240391

subject_name: Herbal medicine (product)

object_name: intracerebral hemorrhage


subject: PUBCHEM.COMPOUND:9953630

subject_name: CODEINE PHOSPHATE

object_name: dyskinesia of esophagus


subject: UNII:GSL05Y1MN6

subject_name: Codeine phosphate hemihydrate


subject: PUBCHEM.COMPOUND:2828


subject: CHEBI:16714

subject_name: Codeine


subject: CHEBI:6801

subject_name: Metformin

object_name: chronic pain (diagnosis)


subject: CHEBI:6801

object_name: Chronic pain


subject: CHEBI:6801

object_name: Disorder of Achilles tendon


subject: CHEBI:6801

object_name: Tendinopathy


subject: UNII:426P9HSR8I

subject_name: PROGERININ

object_name: progeria


subject: DRUGBANK:DB17634

subject_name: Progerinin


subject: CHEBI:63623

subject_name: Succimer

object_name: Asperger syndrome


subject: PR:000022455

subject_name: anaerobic dimethyl sulfoxide reductase chain A

object_name: pervasive developmental disorder


subject: PR:000022455

object_name: autism


subject: PR:000022455


subject: UniProtKB:P18775

subject_name: DMSA_ECOLI Dimethyl sulfoxide reductase DmsA (sprot)


subject: UniProtKB:P18775


subject: UniProtKB:P18775


subject: PUBCHEM.COMPOUND:6096882

subject_name: indocyanine green

object_name: parathyroid gland disorder


subject: PUBCHEM.COMPOUND:6096882

object_name: Abnormality of the parathyroid physiology


subject: PUBCHEM.COMPOUND:6096882

object_name: adenoma


subject: UNII:C4V974V932

subject_name: Indocyanine green acid form


subject: UNII:C4V974V932


subject: UNII:C4V974V932


subject: UNII:DEW6X41BEK

subject_name: Tildrakizumab

object_name: cardiovascular disorder


subject: MESH:D006495

subject_name: Heparin, Low-Molecular-Weight

object_name: Critical Illness


subject: UMLS:C3536766

subject_name: Low Molecular Weight Heparin [EPC]


subject: UMLS:C2825026

subject_name: Unfractionated Heparin [EPC]

object_name: Deep Venous Thrombosis Related to COVID-19


subject: UMLS:C2825026


subject: UNII:K45001587E

subject_name: Celivarone

object_name: Ventricular Arrhythmia by ECG Finding


subject: UNII:K45001587E

object_name: Ventricular arrhythmia


subject: UNII:K45001587E

object_name: Ventricular Arrhythmia, CTCAE 5.0


subject: UNII:K45001587E

object_name: Ventricular Arrhythmia, CTCAE 3.0


subject: GTOPDB:9758

subject_name: camrelizumab

object_name: BCLC Stage C Hepatocellular Carcinoma


subject: UNII:73096E137E


subject: UMLS:C4085979


subject: CHEBI:52763

object_name: leishmaniasis


subject: CHEBI:233362

subject_name: Abemaciclib

object_name: myelodysplastic syndrome with ring sideroblasts


subject: CHEBI:233362

object_name: Stage II Pancreatic Cancer AJCC v8


subject: CHEBI:233362

object_name: leukemia, myeloid, accelerated-phase


subject: CHEBI:233362

object_name: Leukemia, Myeloid, Chronic-Phase


subject: CHEBI:233362

object_name: Blast Phase


subject: CHEBI:233362

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:233362


subject: CHEBI:233362

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: CHEBI:233362

object_name: Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:233362

object_name: atypical chronic myeloid leukemia, BCR-ABL1 negative


subject: CHEBI:233362

object_name: Recurrent Chronic Lymphoid Leukemia


subject: CHEBI:233362

object_name: Recurrent Myeloproliferative Neoplasm


subject: CHEBI:233362

object_name: Recurrent Hematologic Malignancy


subject: CHEBI:233362

object_name: Locally Advanced Pancreatic Adenocarcinoma


subject: CHEBI:233362

object_name: Acute lymphoblastic leukemia recurrent


subject: CHEBI:233362

object_name: Plasma cell myeloma recurrent


subject: CHEBI:233362

object_name: B-cell small lymphocytic lymphoma recurrent


subject: CHEBI:233362

object_name: Refractory Chronic Myelomonocytic Leukemia


subject: CHEBI:233362

object_name: Recurrent Hodgkin Lymphoma


subject: CHEBI:233362

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: CHEBI:233362

object_name: Recurrent Adult Hodgkin Lymphoma


subject: CHEBI:233362

object_name: Unresectable Pancreatic Adenocarcinoma


subject: CHEBI:233362

object_name: Recurrent Myelodysplastic Syndrome


subject: CHEBI:233362

object_name: Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes


subject: CHEBI:233362

object_name: B-cell small lymphocytic lymphoma refractory


subject: CHEBI:233362

object_name: Stage III Non-Hodgkin Lymphoma


subject: CHEBI:233362

object_name: Refractory Acute Lymphoblastic Leukemia


subject: CHEBI:233362

object_name: Chronic lymphocytic leukaemia refractory


subject: CHEBI:233362

object_name: Recurrent Acute Myeloid Leukemia


subject: CHEBI:233362

object_name: Refractory Primary Myelofibrosis


subject: CHEBI:233362

object_name: Stage IV Non-Hodgkin Lymphoma


subject: CHEBI:233362

object_name: Refractory Malignant Solid Neoplasm


subject: CHEBI:233362

object_name: Pancreatic adenocarcinoma metastatic


subject: CHEBI:233362

object_name: Stage III Hodgkin Lymphoma


subject: CHEBI:233362

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: CHEBI:233362

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: CHEBI:233362

object_name: Recurrent Non-Hodgkin Lymphoma


subject: CHEBI:233362

object_name: Refractory Myelodysplastic Syndrome


subject: CHEBI:233362

object_name: Stage IV Hodgkin Lymphoma


subject: CHEBI:233362

object_name: refractory hematologic cancer


subject: CHEBI:233362

object_name: Refractory acute myeloid leukemia


subject: CHEBI:233362

object_name: Non-Hodgkin's lymphoma refractory


subject: CHEBI:233362

object_name: Plasma cell myeloma refractory


subject: CHEBI:233362

object_name: Refractory Hodgkin Lymphoma


subject: CHEBI:233362

object_name: Refractory Childhood Hodgkin Lymphoma


subject: CHEBI:233362

object_name: anemia


subject: CHEBI:233362

object_name: Anemia, CTCAE


subject: CHEBI:233362

object_name: myelofibrosis


subject: PUBCHEM.COMPOUND:21879648

subject_name: Abiraterone

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:21879648

object_name: myelodysplastic syndrome with ring sideroblasts


subject: PUBCHEM.COMPOUND:21879648

object_name: Stage II Pancreatic Cancer AJCC v8


subject: PUBCHEM.COMPOUND:21879648

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: PUBCHEM.COMPOUND:21879648

object_name: Stage III Pancreatic Cancer AJCC v8


subject: PUBCHEM.COMPOUND:21879648

object_name: leukemia, myeloid, accelerated-phase


subject: PUBCHEM.COMPOUND:21879648

object_name: Leukemia, Myeloid, Chronic-Phase


subject: PUBCHEM.COMPOUND:21879648

object_name: Blast Phase


subject: PUBCHEM.COMPOUND:21879648

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: PUBCHEM.COMPOUND:21879648


subject: PUBCHEM.COMPOUND:21879648

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: PUBCHEM.COMPOUND:21879648

object_name: Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: PUBCHEM.COMPOUND:21879648

object_name: atypical chronic myeloid leukemia, BCR-ABL1 negative


subject: PUBCHEM.COMPOUND:21879648

object_name: hematopoietic and lymphoid system neoplasm


subject: PUBCHEM.COMPOUND:21879648

object_name: Recurrent Chronic Lymphoid Leukemia


subject: PUBCHEM.COMPOUND:21879648

object_name: Recurrent Myeloproliferative Neoplasm


subject: PUBCHEM.COMPOUND:21879648

object_name: Recurrent Hematologic Malignancy


subject: PUBCHEM.COMPOUND:21879648

object_name: Locally Advanced Pancreatic Adenocarcinoma


subject: PUBCHEM.COMPOUND:21879648

object_name: Acute lymphoblastic leukemia recurrent


subject: PUBCHEM.COMPOUND:21879648

object_name: Plasma cell myeloma recurrent


subject: PUBCHEM.COMPOUND:21879648

object_name: B-cell small lymphocytic lymphoma recurrent


subject: PUBCHEM.COMPOUND:21879648

object_name: Refractory Chronic Myelomonocytic Leukemia


subject: PUBCHEM.COMPOUND:21879648

object_name: Recurrent Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:21879648

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:21879648

object_name: Recurrent Adult Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:21879648

object_name: Unresectable Pancreatic Adenocarcinoma


subject: PUBCHEM.COMPOUND:21879648

object_name: Recurrent Myelodysplastic Syndrome


subject: PUBCHEM.COMPOUND:21879648

object_name: Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes


subject: PUBCHEM.COMPOUND:21879648

object_name: B-cell small lymphocytic lymphoma refractory


subject: PUBCHEM.COMPOUND:21879648

object_name: Stage III Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:21879648

object_name: Refractory Acute Lymphoblastic Leukemia


subject: PUBCHEM.COMPOUND:21879648

object_name: Chronic lymphocytic leukaemia refractory


subject: PUBCHEM.COMPOUND:21879648

object_name: Recurrent Acute Myeloid Leukemia


subject: PUBCHEM.COMPOUND:21879648

object_name: Refractory Primary Myelofibrosis


subject: PUBCHEM.COMPOUND:21879648

object_name: Stage IV Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:21879648

object_name: Refractory Malignant Solid Neoplasm


subject: PUBCHEM.COMPOUND:21879648

object_name: Metastatic Malignant Solid Neoplasm


subject: PUBCHEM.COMPOUND:21879648

object_name: Pancreatic adenocarcinoma metastatic


subject: PUBCHEM.COMPOUND:21879648

object_name: Stage III Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:21879648

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:21879648

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:21879648

object_name: Recurrent Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:21879648

object_name: Refractory Myelodysplastic Syndrome


subject: PUBCHEM.COMPOUND:21879648

object_name: Stage IV Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:21879648

object_name: refractory hematologic cancer


subject: PUBCHEM.COMPOUND:21879648

object_name: Refractory acute myeloid leukemia


subject: PUBCHEM.COMPOUND:21879648

object_name: Non-Hodgkin's lymphoma refractory


subject: PUBCHEM.COMPOUND:21879648

object_name: Plasma cell myeloma refractory


subject: PUBCHEM.COMPOUND:21879648

object_name: Metastatic Breast Carcinoma


subject: PUBCHEM.COMPOUND:21879648

object_name: Refractory Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:21879648

object_name: Refractory Childhood Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:21879648

object_name: anemia


subject: PUBCHEM.COMPOUND:21879648

object_name: Anemia, CTCAE


subject: PUBCHEM.COMPOUND:21879648

object_name: myelofibrosis


subject: CHEBI:91400

subject_name: Afatinib

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: CHEBI:91400

object_name: Stage IV Prostate Cancer AJCC v8


subject: CHEBI:91400

object_name: myelodysplastic syndrome with ring sideroblasts


subject: CHEBI:91400

object_name: Stage II Pancreatic Cancer AJCC v8


subject: CHEBI:91400

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: CHEBI:91400

object_name: Stage III Pancreatic Cancer AJCC v8


subject: CHEBI:91400

object_name: leukemia, myeloid, accelerated-phase


subject: CHEBI:91400

object_name: Leukemia, Myeloid, Chronic-Phase


subject: CHEBI:91400

object_name: Blast Phase


subject: CHEBI:91400

object_name: castration-resistant prostate carcinoma


subject: CHEBI:91400

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:91400


subject: CHEBI:91400

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: CHEBI:91400

object_name: Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:91400

object_name: atypical chronic myeloid leukemia, BCR-ABL1 negative


subject: CHEBI:91400

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:91400

object_name: Recurrent Chronic Lymphoid Leukemia


subject: CHEBI:91400

object_name: Recurrent Myeloproliferative Neoplasm


subject: CHEBI:91400

object_name: Recurrent Hematologic Malignancy


subject: CHEBI:91400

object_name: Locally Advanced Pancreatic Adenocarcinoma


subject: CHEBI:91400

object_name: Acute lymphoblastic leukemia recurrent


subject: CHEBI:91400

object_name: B-cell small lymphocytic lymphoma recurrent


subject: CHEBI:91400

object_name: Refractory Chronic Myelomonocytic Leukemia


subject: CHEBI:91400

object_name: Recurrent Hodgkin Lymphoma


subject: CHEBI:91400

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: CHEBI:91400

object_name: Recurrent Adult Hodgkin Lymphoma


subject: CHEBI:91400

object_name: Unresectable Pancreatic Adenocarcinoma


subject: CHEBI:91400

object_name: Recurrent Myelodysplastic Syndrome


subject: CHEBI:91400

object_name: Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes


subject: CHEBI:91400

object_name: B-cell small lymphocytic lymphoma refractory


subject: CHEBI:91400

object_name: Stage III Non-Hodgkin Lymphoma


subject: CHEBI:91400

object_name: Refractory Acute Lymphoblastic Leukemia


subject: CHEBI:91400

object_name: Chronic lymphocytic leukaemia refractory


subject: CHEBI:91400

object_name: Recurrent Acute Myeloid Leukemia


subject: CHEBI:91400

object_name: Refractory Primary Myelofibrosis


subject: CHEBI:91400

object_name: Stage IV Non-Hodgkin Lymphoma


subject: CHEBI:91400

object_name: Pancreatic adenocarcinoma metastatic


subject: CHEBI:91400

object_name: Stage III Hodgkin Lymphoma


subject: CHEBI:91400

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: CHEBI:91400

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: CHEBI:91400

object_name: Recurrent Non-Hodgkin Lymphoma


subject: CHEBI:91400

object_name: Refractory Myelodysplastic Syndrome


subject: CHEBI:91400

object_name: Stage IV Hodgkin Lymphoma


subject: CHEBI:91400

object_name: refractory hematologic cancer


subject: CHEBI:91400

object_name: Refractory acute myeloid leukemia


subject: CHEBI:91400

object_name: Non-Hodgkin's lymphoma refractory


subject: CHEBI:91400

object_name: Metastatic Breast Carcinoma


subject: CHEBI:91400

object_name: Refractory Hodgkin Lymphoma


subject: CHEBI:91400

object_name: Refractory Childhood Hodgkin Lymphoma


subject: CHEBI:91400

object_name: anemia


subject: CHEBI:91400

object_name: Anemia, CTCAE


subject: CHEBI:91400

object_name: myelofibrosis


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: myelodysplastic syndrome with ring sideroblasts


subject: UNII:2S9ZZM9Q9V

object_name: leukemia, myeloid, accelerated-phase


subject: UNII:2S9ZZM9Q9V

object_name: Leukemia, Myeloid, Chronic-Phase


subject: UNII:2S9ZZM9Q9V

object_name: castration-resistant prostate carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: UNII:2S9ZZM9Q9V


subject: UNII:2S9ZZM9Q9V

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: UNII:2S9ZZM9Q9V

object_name: Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: UNII:2S9ZZM9Q9V

object_name: atypical chronic myeloid leukemia, BCR-ABL1 negative


subject: UNII:2S9ZZM9Q9V

object_name: Recurrent Chronic Lymphoid Leukemia


subject: UNII:2S9ZZM9Q9V

object_name: Recurrent Myeloproliferative Neoplasm


subject: UNII:2S9ZZM9Q9V

object_name: Recurrent Hematologic Malignancy


subject: UNII:2S9ZZM9Q9V

object_name: Locally Advanced Pancreatic Adenocarcinoma


subject: UNII:2S9ZZM9Q9V

object_name: Acute lymphoblastic leukemia recurrent


subject: UNII:2S9ZZM9Q9V

object_name: B-cell small lymphocytic lymphoma recurrent


subject: UNII:2S9ZZM9Q9V

object_name: Refractory Chronic Myelomonocytic Leukemia


subject: UNII:2S9ZZM9Q9V

object_name: Recurrent Hodgkin Lymphoma


subject: UNII:2S9ZZM9Q9V

object_name: Unresectable Pancreatic Adenocarcinoma


subject: UNII:2S9ZZM9Q9V

object_name: Recurrent Myelodysplastic Syndrome


subject: UNII:2S9ZZM9Q9V

object_name: Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes


subject: UNII:2S9ZZM9Q9V

object_name: B-cell small lymphocytic lymphoma refractory


subject: UNII:2S9ZZM9Q9V

object_name: Stage III Non-Hodgkin Lymphoma


subject: UNII:2S9ZZM9Q9V

object_name: Refractory Acute Lymphoblastic Leukemia


subject: UNII:2S9ZZM9Q9V

object_name: Recurrent Acute Myeloid Leukemia


subject: UNII:2S9ZZM9Q9V

object_name: Refractory Primary Myelofibrosis


subject: UNII:2S9ZZM9Q9V

object_name: Stage IV Non-Hodgkin Lymphoma


subject: UNII:2S9ZZM9Q9V

object_name: Refractory Malignant Solid Neoplasm


subject: UNII:2S9ZZM9Q9V

object_name: Stage III Hodgkin Lymphoma


subject: UNII:2S9ZZM9Q9V

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: UNII:2S9ZZM9Q9V

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: UNII:2S9ZZM9Q9V

object_name: Recurrent Non-Hodgkin Lymphoma


subject: UNII:2S9ZZM9Q9V

object_name: Refractory Myelodysplastic Syndrome


subject: UNII:2S9ZZM9Q9V

object_name: Stage IV Hodgkin Lymphoma


subject: UNII:2S9ZZM9Q9V

object_name: refractory hematologic cancer


subject: UNII:2S9ZZM9Q9V

object_name: Refractory acute myeloid leukemia


subject: UNII:2S9ZZM9Q9V

object_name: Non-Hodgkin's lymphoma refractory


subject: UNII:2S9ZZM9Q9V

object_name: Plasma cell myeloma refractory


subject: UNII:2S9ZZM9Q9V

object_name: Metastatic Breast Carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: Refractory Hodgkin Lymphoma


subject: UNII:2S9ZZM9Q9V

object_name: Refractory Childhood Hodgkin Lymphoma


subject: UNII:2S9ZZM9Q9V

object_name: anemia


subject: UNII:2S9ZZM9Q9V

object_name: Anemia, CTCAE


subject: CHEBI:144094

subject_name: bicalutamide

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: CHEBI:144094

object_name: myelodysplastic syndrome with ring sideroblasts


subject: CHEBI:144094

object_name: Stage II Pancreatic Cancer AJCC v8


subject: CHEBI:144094

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: CHEBI:144094

object_name: Stage III Pancreatic Cancer AJCC v8


subject: CHEBI:144094

object_name: leukemia, myeloid, accelerated-phase


subject: CHEBI:144094

object_name: Leukemia, Myeloid, Chronic-Phase


subject: CHEBI:144094

object_name: Blast Phase


subject: CHEBI:144094

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:144094


subject: CHEBI:144094

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: CHEBI:144094

object_name: Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:144094

object_name: atypical chronic myeloid leukemia, BCR-ABL1 negative


subject: CHEBI:144094

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:144094

object_name: Recurrent Chronic Lymphoid Leukemia


subject: CHEBI:144094

object_name: Recurrent Myeloproliferative Neoplasm


subject: CHEBI:144094

object_name: Recurrent Hematologic Malignancy


subject: CHEBI:144094

object_name: Locally Advanced Pancreatic Adenocarcinoma


subject: CHEBI:144094

object_name: Acute lymphoblastic leukemia recurrent


subject: CHEBI:144094

object_name: Plasma cell myeloma recurrent


subject: CHEBI:144094

object_name: B-cell small lymphocytic lymphoma recurrent


subject: CHEBI:144094

object_name: Refractory Chronic Myelomonocytic Leukemia


subject: CHEBI:144094

object_name: Recurrent Hodgkin Lymphoma


subject: CHEBI:144094

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: CHEBI:144094

object_name: Recurrent Adult Hodgkin Lymphoma


subject: CHEBI:144094

object_name: Unresectable Pancreatic Adenocarcinoma


subject: CHEBI:144094

object_name: Recurrent Myelodysplastic Syndrome


subject: CHEBI:144094

object_name: Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes


subject: CHEBI:144094

object_name: B-cell small lymphocytic lymphoma refractory


subject: CHEBI:144094

object_name: Stage III Non-Hodgkin Lymphoma


subject: CHEBI:144094

object_name: Refractory Acute Lymphoblastic Leukemia


subject: CHEBI:144094

object_name: Chronic lymphocytic leukaemia refractory


subject: CHEBI:144094

object_name: Recurrent Acute Myeloid Leukemia


subject: CHEBI:144094

object_name: Refractory Primary Myelofibrosis


subject: CHEBI:144094

object_name: Stage IV Non-Hodgkin Lymphoma


subject: CHEBI:144094

object_name: Refractory Malignant Solid Neoplasm


subject: CHEBI:144094

object_name: Metastatic Malignant Solid Neoplasm


subject: CHEBI:144094

object_name: Pancreatic adenocarcinoma metastatic


subject: CHEBI:144094

object_name: Stage III Hodgkin Lymphoma


subject: CHEBI:144094

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: CHEBI:144094

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: CHEBI:144094

object_name: Recurrent Non-Hodgkin Lymphoma


subject: CHEBI:144094

object_name: Refractory Myelodysplastic Syndrome


subject: CHEBI:144094

object_name: Stage IV Hodgkin Lymphoma


subject: CHEBI:144094

object_name: refractory hematologic cancer


subject: CHEBI:144094

object_name: Refractory acute myeloid leukemia


subject: CHEBI:144094

object_name: Non-Hodgkin's lymphoma refractory


subject: CHEBI:144094

object_name: Plasma cell myeloma refractory


subject: CHEBI:144094

object_name: Metastatic Breast Carcinoma


subject: CHEBI:144094

object_name: Refractory Hodgkin Lymphoma


subject: CHEBI:144094

object_name: Refractory Childhood Hodgkin Lymphoma


subject: CHEBI:144094

object_name: anemia


subject: CHEBI:144094

object_name: Anemia, CTCAE


subject: CHEBI:144094

object_name: myelofibrosis


subject: CHEBI:52717

subject_name: Bortezomib

object_name: Stage IV Prostate Cancer AJCC v8


subject: CHEBI:52717

object_name: myelodysplastic syndrome with ring sideroblasts


subject: CHEBI:52717

object_name: Stage II Pancreatic Cancer AJCC v8


subject: CHEBI:52717

object_name: Stage III Pancreatic Cancer AJCC v8


subject: CHEBI:52717

object_name: leukemia, myeloid, accelerated-phase


subject: CHEBI:52717

object_name: Leukemia, Myeloid, Chronic-Phase


subject: CHEBI:52717

object_name: castration-resistant prostate carcinoma


subject: CHEBI:52717


subject: CHEBI:52717

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: CHEBI:52717

object_name: Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:52717

object_name: atypical chronic myeloid leukemia, BCR-ABL1 negative


subject: CHEBI:52717

object_name: Recurrent Chronic Lymphoid Leukemia


subject: CHEBI:52717

object_name: Recurrent Myeloproliferative Neoplasm


subject: CHEBI:52717

object_name: Recurrent Hematologic Malignancy


subject: CHEBI:52717

object_name: Locally Advanced Pancreatic Adenocarcinoma


subject: CHEBI:52717

object_name: Refractory Chronic Myelomonocytic Leukemia


subject: CHEBI:52717

object_name: Recurrent Hodgkin Lymphoma


subject: CHEBI:52717

object_name: Unresectable Pancreatic Adenocarcinoma


subject: CHEBI:52717

object_name: Recurrent Myelodysplastic Syndrome


subject: CHEBI:52717

object_name: Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes


subject: CHEBI:52717

object_name: B-cell small lymphocytic lymphoma refractory


subject: CHEBI:52717

object_name: Stage III Non-Hodgkin Lymphoma


subject: CHEBI:52717

object_name: Recurrent Acute Myeloid Leukemia


subject: CHEBI:52717

object_name: Refractory Primary Myelofibrosis


subject: CHEBI:52717

object_name: Stage IV Non-Hodgkin Lymphoma


subject: CHEBI:52717

object_name: Refractory Malignant Solid Neoplasm


subject: CHEBI:52717

object_name: Metastatic Malignant Solid Neoplasm


subject: CHEBI:52717

object_name: Pancreatic adenocarcinoma metastatic


subject: CHEBI:52717

object_name: Stage III Hodgkin Lymphoma


subject: CHEBI:52717

object_name: Refractory Myelodysplastic Syndrome


subject: CHEBI:52717

object_name: Stage IV Hodgkin Lymphoma


subject: CHEBI:52717

object_name: refractory hematologic cancer


subject: CHEBI:52717

object_name: Refractory acute myeloid leukemia


subject: CHEBI:52717

object_name: Non-Hodgkin's lymphoma refractory


subject: CHEBI:52717

object_name: Refractory Hodgkin Lymphoma


subject: CHEBI:52717

object_name: Refractory Childhood Hodgkin Lymphoma


subject: CHEBI:52717

object_name: anemia


subject: CHEBI:52717

object_name: Anemia, CTCAE


subject: CHEBI:63584

subject_name: Cabazitaxel

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: CHEBI:63584

object_name: Stage IV Prostate Cancer AJCC v8


subject: CHEBI:63584

object_name: myelodysplastic syndrome with ring sideroblasts


subject: CHEBI:63584

object_name: Stage II Pancreatic Cancer AJCC v8


subject: CHEBI:63584

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: CHEBI:63584

object_name: Stage III Pancreatic Cancer AJCC v8


subject: CHEBI:63584

object_name: leukemia, myeloid, accelerated-phase


subject: CHEBI:63584

object_name: Leukemia, Myeloid, Chronic-Phase


subject: CHEBI:63584

object_name: Blast Phase


subject: CHEBI:63584

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:63584


subject: CHEBI:63584

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: CHEBI:63584

object_name: Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:63584

object_name: atypical chronic myeloid leukemia, BCR-ABL1 negative


subject: CHEBI:63584

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:63584

object_name: Recurrent Chronic Lymphoid Leukemia


subject: CHEBI:63584

object_name: Recurrent Myeloproliferative Neoplasm


subject: CHEBI:63584

object_name: Recurrent Hematologic Malignancy


subject: CHEBI:63584

object_name: Locally Advanced Pancreatic Adenocarcinoma


subject: CHEBI:63584

object_name: Acute lymphoblastic leukemia recurrent


subject: CHEBI:63584

object_name: Plasma cell myeloma recurrent


subject: CHEBI:63584

object_name: B-cell small lymphocytic lymphoma recurrent


subject: CHEBI:63584

object_name: Refractory Chronic Myelomonocytic Leukemia


subject: CHEBI:63584

object_name: Recurrent Hodgkin Lymphoma


subject: CHEBI:63584

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: CHEBI:63584

object_name: Recurrent Adult Hodgkin Lymphoma


subject: CHEBI:63584

object_name: Unresectable Pancreatic Adenocarcinoma


subject: CHEBI:63584

object_name: Recurrent Myelodysplastic Syndrome


subject: CHEBI:63584

object_name: Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes


subject: CHEBI:63584

object_name: B-cell small lymphocytic lymphoma refractory


subject: CHEBI:63584

object_name: Stage III Non-Hodgkin Lymphoma


subject: CHEBI:63584

object_name: Refractory Acute Lymphoblastic Leukemia


subject: CHEBI:63584

object_name: Chronic lymphocytic leukaemia refractory


subject: CHEBI:63584

object_name: Recurrent Acute Myeloid Leukemia


subject: CHEBI:63584

object_name: Refractory Primary Myelofibrosis


subject: CHEBI:63584

object_name: Stage IV Non-Hodgkin Lymphoma


subject: CHEBI:63584

object_name: Refractory Malignant Solid Neoplasm


subject: CHEBI:63584

object_name: Metastatic Malignant Solid Neoplasm


subject: CHEBI:63584

object_name: Pancreatic adenocarcinoma metastatic


subject: CHEBI:63584

object_name: Stage III Hodgkin Lymphoma


subject: CHEBI:63584

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: CHEBI:63584

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: CHEBI:63584

object_name: Recurrent Non-Hodgkin Lymphoma


subject: CHEBI:63584

object_name: Refractory Myelodysplastic Syndrome


subject: CHEBI:63584

object_name: Stage IV Hodgkin Lymphoma


subject: CHEBI:63584

object_name: refractory hematologic cancer


subject: CHEBI:63584

object_name: Refractory acute myeloid leukemia


subject: CHEBI:63584

object_name: Non-Hodgkin's lymphoma refractory


subject: CHEBI:63584

object_name: Plasma cell myeloma refractory


subject: CHEBI:63584

object_name: Metastatic Breast Carcinoma


subject: CHEBI:63584

object_name: Refractory Hodgkin Lymphoma


subject: CHEBI:63584

object_name: Refractory Childhood Hodgkin Lymphoma


subject: CHEBI:63584

object_name: anemia


subject: CHEBI:63584

object_name: Anemia, CTCAE


subject: CHEBI:63584

object_name: myelofibrosis


subject: CHEBI:72317

subject_name: Cabozantinib

object_name: myelodysplastic syndrome with ring sideroblasts


subject: CHEBI:72317

object_name: Stage II Pancreatic Cancer AJCC v8


subject: CHEBI:72317

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: CHEBI:72317

object_name: Stage III Pancreatic Cancer AJCC v8


subject: CHEBI:72317

object_name: leukemia, myeloid, accelerated-phase


subject: CHEBI:72317

object_name: Leukemia, Myeloid, Chronic-Phase


subject: CHEBI:72317

object_name: Blast Phase


subject: CHEBI:72317

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:72317


subject: CHEBI:72317

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: CHEBI:72317

object_name: Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:72317

object_name: atypical chronic myeloid leukemia, BCR-ABL1 negative


subject: CHEBI:72317

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:72317

object_name: Recurrent Chronic Lymphoid Leukemia


subject: CHEBI:72317

object_name: Recurrent Myeloproliferative Neoplasm


subject: CHEBI:72317

object_name: Recurrent Hematologic Malignancy


subject: CHEBI:72317

object_name: Locally Advanced Pancreatic Adenocarcinoma


subject: CHEBI:72317

object_name: Acute lymphoblastic leukemia recurrent


subject: CHEBI:72317

object_name: Plasma cell myeloma recurrent


subject: CHEBI:72317

object_name: B-cell small lymphocytic lymphoma recurrent


subject: CHEBI:72317

object_name: Refractory Chronic Myelomonocytic Leukemia


subject: CHEBI:72317

object_name: Recurrent Hodgkin Lymphoma


subject: CHEBI:72317

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: CHEBI:72317

object_name: Recurrent Adult Hodgkin Lymphoma


subject: CHEBI:72317

object_name: Unresectable Pancreatic Adenocarcinoma


subject: CHEBI:72317

object_name: Recurrent Myelodysplastic Syndrome


subject: CHEBI:72317

object_name: Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes


subject: CHEBI:72317

object_name: B-cell small lymphocytic lymphoma refractory


subject: CHEBI:72317

object_name: Stage III Non-Hodgkin Lymphoma


subject: CHEBI:72317

object_name: Refractory Acute Lymphoblastic Leukemia


subject: CHEBI:72317

object_name: Chronic lymphocytic leukaemia refractory


subject: CHEBI:72317

object_name: Recurrent Acute Myeloid Leukemia


subject: CHEBI:72317

object_name: Refractory Primary Myelofibrosis


subject: CHEBI:72317

object_name: Stage IV Non-Hodgkin Lymphoma


subject: CHEBI:72317

object_name: Stage III Hodgkin Lymphoma


subject: CHEBI:72317

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: CHEBI:72317

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: CHEBI:72317

object_name: Recurrent Non-Hodgkin Lymphoma


subject: CHEBI:72317

object_name: Refractory Myelodysplastic Syndrome


subject: CHEBI:72317

object_name: Stage IV Hodgkin Lymphoma


subject: CHEBI:72317

object_name: refractory hematologic cancer


subject: CHEBI:72317

object_name: Non-Hodgkin's lymphoma refractory


subject: CHEBI:72317

object_name: Metastatic Breast Carcinoma


subject: CHEBI:72317

object_name: Refractory Hodgkin Lymphoma


subject: CHEBI:72317

object_name: Refractory Childhood Hodgkin Lymphoma


subject: CHEBI:72317

object_name: anemia


subject: CHEBI:72317

object_name: Anemia, CTCAE


subject: CHEBI:72317

object_name: myelofibrosis


subject: CHEBI:31348

subject_name: Capecitabine

object_name: Stage IV Prostate Cancer AJCC v8


subject: CHEBI:31348

object_name: myelodysplastic syndrome with ring sideroblasts


subject: CHEBI:31348

object_name: leukemia, myeloid, accelerated-phase


subject: CHEBI:31348

object_name: Leukemia, Myeloid, Chronic-Phase


subject: CHEBI:31348

object_name: Blast Phase


subject: CHEBI:31348

object_name: castration-resistant prostate carcinoma


subject: CHEBI:31348

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:31348


subject: CHEBI:31348

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: CHEBI:31348

object_name: Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:31348

object_name: atypical chronic myeloid leukemia, BCR-ABL1 negative


subject: CHEBI:31348

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:31348

object_name: Recurrent Chronic Lymphoid Leukemia


subject: CHEBI:31348

object_name: Recurrent Myeloproliferative Neoplasm


subject: CHEBI:31348

object_name: Recurrent Hematologic Malignancy


subject: CHEBI:31348

object_name: Acute lymphoblastic leukemia recurrent


subject: CHEBI:31348

object_name: Plasma cell myeloma recurrent


subject: CHEBI:31348

object_name: Refractory Chronic Myelomonocytic Leukemia


subject: CHEBI:31348

object_name: Recurrent Hodgkin Lymphoma


subject: CHEBI:31348

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: CHEBI:31348

object_name: Unresectable Pancreatic Adenocarcinoma


subject: CHEBI:31348

object_name: Recurrent Myelodysplastic Syndrome


subject: CHEBI:31348

object_name: Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes


subject: CHEBI:31348

object_name: B-cell small lymphocytic lymphoma refractory


subject: CHEBI:31348

object_name: Stage III Non-Hodgkin Lymphoma


subject: CHEBI:31348

object_name: Refractory Acute Lymphoblastic Leukemia


subject: CHEBI:31348

object_name: Chronic lymphocytic leukaemia refractory


subject: CHEBI:31348

object_name: Recurrent Acute Myeloid Leukemia


subject: CHEBI:31348

object_name: Refractory Primary Myelofibrosis


subject: CHEBI:31348

object_name: Stage IV Non-Hodgkin Lymphoma


subject: CHEBI:31348

object_name: Refractory Malignant Solid Neoplasm


subject: CHEBI:31348

object_name: Stage III Hodgkin Lymphoma


subject: CHEBI:31348

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: CHEBI:31348

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: CHEBI:31348

object_name: Recurrent Non-Hodgkin Lymphoma


subject: CHEBI:31348

object_name: Refractory Myelodysplastic Syndrome


subject: CHEBI:31348

object_name: Stage IV Hodgkin Lymphoma


subject: CHEBI:31348

object_name: refractory hematologic cancer


subject: CHEBI:31348

object_name: Refractory acute myeloid leukemia


subject: CHEBI:31348

object_name: Non-Hodgkin's lymphoma refractory


subject: CHEBI:31348

object_name: Plasma cell myeloma refractory


subject: CHEBI:31348

object_name: Metastatic Breast Carcinoma


subject: CHEBI:31348

object_name: Refractory Hodgkin Lymphoma


subject: CHEBI:31348

object_name: Refractory Childhood Hodgkin Lymphoma


subject: CHEBI:31348

object_name: anemia


subject: CHEBI:31348

object_name: Anemia, CTCAE


subject: CHEBI:31348

object_name: myelofibrosis


subject: CHEBI:31355

subject_name: Carboplatin

object_name: myelodysplastic syndrome with ring sideroblasts


subject: CHEBI:31355

object_name: leukemia, myeloid, accelerated-phase


subject: CHEBI:31355

object_name: Leukemia, Myeloid, Chronic-Phase


subject: CHEBI:31355

object_name: Blast Phase


subject: CHEBI:31355

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:31355


subject: CHEBI:31355

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: CHEBI:31355

object_name: Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:31355

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:31355

object_name: Recurrent Chronic Lymphoid Leukemia


subject: CHEBI:31355

object_name: Recurrent Myeloproliferative Neoplasm


subject: CHEBI:31355

object_name: Recurrent Hematologic Malignancy


subject: CHEBI:31355

object_name: Locally Advanced Pancreatic Adenocarcinoma


subject: CHEBI:31355

object_name: Acute lymphoblastic leukemia recurrent


subject: CHEBI:31355

object_name: Plasma cell myeloma recurrent


subject: CHEBI:31355

object_name: Refractory Chronic Myelomonocytic Leukemia


subject: CHEBI:31355

object_name: Unresectable Pancreatic Adenocarcinoma


subject: CHEBI:31355

object_name: Recurrent Myelodysplastic Syndrome


subject: CHEBI:31355

object_name: Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes


subject: CHEBI:31355

object_name: B-cell small lymphocytic lymphoma refractory


subject: CHEBI:31355

object_name: Stage III Non-Hodgkin Lymphoma


subject: CHEBI:31355

object_name: Refractory Acute Lymphoblastic Leukemia


subject: CHEBI:31355

object_name: Recurrent Acute Myeloid Leukemia


subject: CHEBI:31355

object_name: Refractory Primary Myelofibrosis


subject: CHEBI:31355

object_name: Stage IV Non-Hodgkin Lymphoma


subject: CHEBI:31355

object_name: Refractory Malignant Solid Neoplasm


subject: CHEBI:31355

object_name: Pancreatic adenocarcinoma metastatic


subject: CHEBI:31355

object_name: Stage III Hodgkin Lymphoma


subject: CHEBI:31355

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: CHEBI:31355

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: CHEBI:31355

object_name: Recurrent Non-Hodgkin Lymphoma


subject: CHEBI:31355

object_name: Refractory Myelodysplastic Syndrome


subject: CHEBI:31355

object_name: Stage IV Hodgkin Lymphoma


subject: CHEBI:31355

object_name: refractory hematologic cancer


subject: CHEBI:31355

object_name: Refractory acute myeloid leukemia


subject: CHEBI:31355

object_name: myelofibrosis


subject: CHEBI:41423

subject_name: Celecoxib

object_name: Stage IV Prostate Cancer AJCC v8


subject: CHEBI:41423

object_name: myelodysplastic syndrome with ring sideroblasts


subject: CHEBI:41423

object_name: Stage II Pancreatic Cancer AJCC v8


subject: CHEBI:41423

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: CHEBI:41423

object_name: Stage III Pancreatic Cancer AJCC v8


subject: CHEBI:41423

object_name: leukemia, myeloid, accelerated-phase


subject: CHEBI:41423

object_name: Leukemia, Myeloid, Chronic-Phase


subject: CHEBI:41423

object_name: Blast Phase


subject: CHEBI:41423

object_name: castration-resistant prostate carcinoma


subject: CHEBI:41423

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:41423


subject: CHEBI:41423

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: CHEBI:41423

object_name: Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:41423

object_name: atypical chronic myeloid leukemia, BCR-ABL1 negative


subject: CHEBI:41423

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:41423

object_name: Recurrent Chronic Lymphoid Leukemia


subject: CHEBI:41423

object_name: Recurrent Myeloproliferative Neoplasm


subject: CHEBI:41423

object_name: Recurrent Hematologic Malignancy


subject: CHEBI:41423

object_name: Locally Advanced Pancreatic Adenocarcinoma


subject: CHEBI:41423

object_name: Acute lymphoblastic leukemia recurrent


subject: CHEBI:41423

object_name: Plasma cell myeloma recurrent


subject: CHEBI:41423

object_name: B-cell small lymphocytic lymphoma recurrent


subject: CHEBI:41423

object_name: Refractory Chronic Myelomonocytic Leukemia


subject: CHEBI:41423

object_name: Recurrent Hodgkin Lymphoma


subject: CHEBI:41423

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: CHEBI:41423

object_name: Recurrent Adult Hodgkin Lymphoma


subject: CHEBI:41423

object_name: Unresectable Pancreatic Adenocarcinoma


subject: CHEBI:41423

object_name: Recurrent Myelodysplastic Syndrome


subject: CHEBI:41423

object_name: Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes


subject: CHEBI:41423

object_name: B-cell small lymphocytic lymphoma refractory


subject: CHEBI:41423

object_name: Stage III Non-Hodgkin Lymphoma


subject: CHEBI:41423

object_name: Refractory Acute Lymphoblastic Leukemia


subject: CHEBI:41423

object_name: Chronic lymphocytic leukaemia refractory


subject: CHEBI:41423

object_name: Recurrent Acute Myeloid Leukemia


subject: CHEBI:41423

object_name: Refractory Primary Myelofibrosis


subject: CHEBI:41423

object_name: Stage IV Non-Hodgkin Lymphoma


subject: CHEBI:41423

object_name: Refractory Malignant Solid Neoplasm


subject: CHEBI:41423

object_name: Metastatic Malignant Solid Neoplasm


subject: CHEBI:41423

object_name: Pancreatic adenocarcinoma metastatic


subject: CHEBI:41423

object_name: Stage III Hodgkin Lymphoma


subject: CHEBI:41423

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: CHEBI:41423

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: CHEBI:41423

object_name: Recurrent Non-Hodgkin Lymphoma


subject: CHEBI:41423

object_name: Refractory Myelodysplastic Syndrome


subject: CHEBI:41423

object_name: Stage IV Hodgkin Lymphoma


subject: CHEBI:41423

object_name: refractory hematologic cancer


subject: CHEBI:41423

object_name: Refractory acute myeloid leukemia


subject: CHEBI:41423

object_name: Non-Hodgkin's lymphoma refractory


subject: CHEBI:41423

object_name: Plasma cell myeloma refractory


subject: CHEBI:41423

object_name: Metastatic Breast Carcinoma


subject: CHEBI:41423

object_name: Refractory Hodgkin Lymphoma


subject: CHEBI:41423

object_name: Refractory Childhood Hodgkin Lymphoma


subject: CHEBI:41423

object_name: anemia


subject: CHEBI:41423

object_name: Anemia, CTCAE


subject: CHEBI:41423

object_name: myelofibrosis


subject: PUBCHEM.COMPOUND:51038893

subject_name: Cobimetinib

object_name: Stage IV Prostate Cancer AJCC v8


subject: PUBCHEM.COMPOUND:51038893

object_name: myelodysplastic syndrome with ring sideroblasts


subject: PUBCHEM.COMPOUND:51038893

object_name: leukemia, myeloid, accelerated-phase


subject: PUBCHEM.COMPOUND:51038893

object_name: Leukemia, Myeloid, Chronic-Phase


subject: PUBCHEM.COMPOUND:51038893

object_name: Blast Phase


subject: PUBCHEM.COMPOUND:51038893

object_name: castration-resistant prostate carcinoma


subject: PUBCHEM.COMPOUND:51038893

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: PUBCHEM.COMPOUND:51038893


subject: PUBCHEM.COMPOUND:51038893

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: PUBCHEM.COMPOUND:51038893

object_name: Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: PUBCHEM.COMPOUND:51038893

object_name: atypical chronic myeloid leukemia, BCR-ABL1 negative


subject: PUBCHEM.COMPOUND:51038893

object_name: Recurrent Chronic Lymphoid Leukemia


subject: PUBCHEM.COMPOUND:51038893

object_name: Recurrent Myeloproliferative Neoplasm


subject: PUBCHEM.COMPOUND:51038893

object_name: Recurrent Hematologic Malignancy


subject: PUBCHEM.COMPOUND:51038893

object_name: Acute lymphoblastic leukemia recurrent